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ZUSAMMENFASSUNG
Die Magnetresonanztomographie (MRT)-basierte Kartierung der Gewebeoxygenierung wäre für die Be-
handlung von Patienten mit Hirntumoren äußerst hilfreich. Das Ziel dieser Arbeit war daher die quan-
titative Suszeptibilitätskartierung (QSM) in die Rekonstruktion des Sauerstoffextraktionsanteils (OEF), des
zerebralen Blutflusses (CBF) und der zerebralen Sauerstoffumsatzrate (CMRO2) einzubinden. Im ersten
Teil wurde ein kombinierter QSM und quantitativer blutsauerstoffabhängiger (qBOLD) Ansatz für zwei
verschiedene MRT Sequenzen, gradientenecho-abgetastetes Spinecho (GESSE) und Multi-Gradientenecho
(GRE), in sieben gesunden Probanden und Simulationen verglichen. GESSE ergab eine höhere Parameter-
genauigkeit in simulierter Grauer Substanz, produzierte aber einen unphysiologischen Kontrast zwis-
chen Grauer und Weißer Substanz im OEF in vivo. GRE ist effizienter und erzeugte homogene OEF Karten
in vivo, zeigte aber Ungenauigkeiten in der Simulation. Im zweiten Teil wurde ein künstliches neur-
onales Netz (ANN) für QSM+qBOLD trainiert und mit dem initialen quasi-Newton (QN) Ansatz verglichen.
Das ANN ermöglichte eine schnellere und robustere Rekonstruktion von OEF Karten mit einer geringeren
individuellen Variation (OEFANN = 43.5 ± 0.8 % vs OEFQN = 43.8 ± 5.2 %). Im dritten Teil wurde Clus-
tering, eine Technik aus dem maschinellen Lernen, in den QN-Ansatz der QSM+qBOLD Analyse von GRE
Daten integriert und auf acht Patienten mit hochgradigen Gliomen angewendet. Der OEF war innerhalb
des Tumors signifikant niedriger als auf der kontralateralen Seite bei Grad III (OEFtum = 12.5 ± 0.5 %
vs OEFcon = 24.5 ± 2.3 %) und Grad IV (OEFtum = 17.2 ± 6.1 % vs OEFcon = 24.8 ± 4.5 %) Gliomen. Der
CBF war signifikant höher, allerdings nur bei Grad IV Gliomen (CBFtum = 108.1± 83.3 ml/100 g/min vs
CBFcon = 29.1± 21.0 ml/100 g/min). Die CMRO2 zeigte keine signifikanten Unterschiede. Das Nutzen der
Phase und Magnitude des gemessenen MRT-Signals und die Einbeziehung maschinellen Lernens für die
Rekonstruktion des OEF mittels QSM+qBOLD ist vielversprechend und könnte die Implementierung einer
robusten Quantifizierung der Gewebeoxygenierung in der klinischen Routine in Zukunft ermöglichen.
ABSTRACT
Magnetic resonance imaging (MRI)-based mapping of the tissue oxygenation would be highly beneficial
for the treatment of patients with brain tumours. Hence, the purpose of this thesis was to incorporate
quantitative susceptibility mapping (QSM) into a reconstruction of the oxygen extraction fraction (OEF),
cerebral blood flow (CBF) and cerebral metabolic rate of oxygen (CMRO2). In the first part, a joint QSM
and quantitative blood oxygenation level-dependent (qBOLD) approach from two different MRI sequences,
gradient echo sampling of spin echo (GESSE) and multi-gradient echo (GRE), was compared in seven
healthy subjects and simulations. GESSE yielded higher parameter accuracy in simulated grey matter
but produced unphysiological grey–white matter contrast in OEF in vivo. GRE is more efficient and gen-
erated uniform OEF maps in vivo but revealed biases in simulation. In the second part, an artificial
neural network (ANN) was trained for QSM+qBOLD analysis and compared to the initial quasi-Newton (QN)
reconstruction. The ANN allowed a faster and more robust reconstruction of OEF maps with lower in-
tersubject variation (OEFANN = 43.5± 0.8 % vs OEFQN = 43.8± 5.2 %). In the third part, machine learning-
based clustering was incorporated into the QN QSM+qBOLD analysis and applied to eight patients with
high-grade gliomas. The OEF was significantly lower inside the tumour compared to the contralateral
side in grade III (OEFtum = 12.5 ± 0.5 % vs OEFcon = 24.5 ± 2.3 %) and grade IV (OEFtum = 17.2 ± 6.1 %
vs OEFcon = 24.8 ± 4.5 %) gliomas. The CBF was significantly higher; yet, only in grade IV gliomas
(CBFtum = 108.1± 83.3 ml/100 g/min vs CBFcon = 29.1± 21.0 ml/100 g/min). The CMRO2 revealed no signifi-
cant differences. Exploiting the phase and magnitude of the acquired MRI signal and including machine
learning for reconstruction of the OEF with QSM+qBOLD is promising and might facilitate the implementa-
tion of a robust quantification of the tissue oxygenation in the clinical routine in the future.
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1
I N T R O D U C T I O N
257, 000 new cases of cancer in the brain and the central nervous system (CNS)
were estimated worldwide in 2012 [Ferlay et al., 2015]. In addition, an ex-
pected 187, 000 people died from these cancer types in the same year [Ferlay
et al., 2015]. With regard to malignant primary brain tumours, glioblastoma
multiforme is the most common type comprising around 42− 49 % of new
cases each year [Wen and Kesari, 2008]. Due to the aggressive infiltration of
the surrounding tissue, the median survival time of glioblastoma patients is
only 12 to 15 months [Wen and Kesari, 2008].
Glioblastomas are commonly first surgically resected and subsequently
treated with radio- and chemotherapy [Furnari et al., 2007; Buatti et al., 2008].
Due to its strong soft tissue contrast, magnetic resonance imaging (MRI) is
the means of choice for imaging brain tumours for diagnosis, treatment plan-
ning and assessment of treatment response. Currently, contrast-enhanced T1-
weighted MRI is widely used to assess the morphology of glioblastomas as
damages in the blood-brain barrier allow the contrast agent to accumulate in-
side the tissue. However, this approach is unable to detect tumour infiltration
prior to disruption of the blood-brain barrier [Young, 2007].
Functional imaging would be advantageous for this task and the oxygen
extraction fraction (OEF) and the cerebral metabolic rate of oxygen (CMRO2)
have shown to be promising biomarkers for tissue vitality and viability in
numerous diseases, such as stroke [An et al., 2014; Ibaraki et al., 2004], ca-
rotid artery stenosis [Kudo et al., 2016], multiple sclerosis [Fan et al., 2014]
and obstructive sleep apnea [Rodgers et al., 2016]. Moreover, the knowledge
of the tissue oxygenation is highly valuable for radiotherapy treatment of
brain tumours since it affects the radiosensitivity of the tissue [Hockel et al.,
1996; Vaupel and Mayer, 2007; Rofstad et al., 2000; Wang et al., 2006; Søvik
et al., 2009]. Furthermore, tissue oxygenation parameters, such as the OEF,
have proven to be even capable of tumour grading [Stadlbauer et al., 2017].
The current gold standard for OEF/CMRO2 measurements is positron emission
tomography (PET) with 15O as a tracer. Yet, the half-life of 15O is only around
2 minutes, which renders this method technically demanding and costly as it
requires a cyclotron on-site.
MRI-based mapping of the brain oxygenation has been an area of exten-
sive research for over 25 years [Yablonskiy and Haacke, 1994; Christen et al.,
2012; Bolar et al., 2011; Zhang et al., 2015]. Several approaches to evaluate
the OEF for instance have been proposed over the years, the most prominent
being the quantitative blood oxygenation level-dependent (qBOLD) technique
[Yablonskiy and Haacke, 1994; Yablonskiy, 1998; He and Yablonskiy, 2007],
which models the effects of physiological and oxygenation parameters on the
magnitude of the MRI signal. Nevertheless, the qBOLD approach has not yet
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2 introduction
been adopted in the clinical routine as the complex tissue model requires an
exceedingly high signal to noise ratio (SNR) in order to accurately disentangle
its parameters. In 2010, a postprocessing method called quantitative suscep-
tibility mapping (QSM) was proposed [De Rochefort et al., 2010], which re-
constructs the magnetic susceptibility from the phase of the MRI signal. Since
then, various approaches [Fan et al., 2014; Zhang et al., 2015; Kudo et al., 2016;
Zhang et al., 2017, 2018] have been suggested to infer the OEF also from QSM;
yet, these methods necessitate some form of vascular challenge [Zhang et al.,
2015, 2017], strong physiological approximations [Zhang et al., 2018] or are
restricted to large veins [Fan et al., 2014].
Hence, Cho et al. [2018] proposed to combine qBOLD and QSM into one
reconstruction, which allows to exploit the full information of the acquired
MRI signal, i. e. the magnitude and phase. Moreover, QSM, which shows good
repeatability [Feng et al., 2018], can act as an independent measurement to
regularise the less robust qBOLD reconstruction. Cho et al. [2018] used a multi-
gradient echo (GRE) sequence for their combined approach and applied the
qBOLD model of Ulrich and Yablonskiy [2016] for reconstruction. Despite the
good performance of the model in grey matter, it was biased in white mat-
ter when sampling with short echo times owing to the fast T2 component
associated with myelin [Ulrich and Yablonskiy, 2016; Whittall et al., 1997].
Furthermore, the resulting parameter maps greatly depended on the initial
guess of OEF and deoxygenated blood volume ν; thus, requiring a mask of
the straight sinus and an additional arterial spin labelling (ASL) acquisition
respectively. Lastly, the approach has so far only been tested in healthy volun-
teers and its performance in pathologies affecting the oxygenation status of
the brain is yet unknown.
It is therefore that the overall objective of this thesis was to incorporate
QSM into a qBOLD-based reconstruction of the OEF and CMRO2. This method
was then optimised with regard to sensitivity and robustness and applied to
patients with high-grade gliomas as a first step to facilitate a clinical imple-
mentation in the future. This thesis consists of three main parts.
In the first part, the performance of two different MRI sequences for com-
bined QSM and qBOLD analysis (QSM+qBOLD) was compared. The OEF and de-
oxygenated blood volume ν are strongly coupled in the qBOLD model. Hence,
an accurate and precise parameter reconstruction requires the separation of
the so-called long-term regime, where the logarithmic signal decays linearly
with OEF and the short-term regime, where it decays quadratically. Merely
sampling the free induction decay (FID) with GRE restricts the short-term re-
gime to the first few echoes after excitation, making a robust parameter sep-
aration difficult [Yablonskiy and Haacke, 1997]. However, including a spin
echo (SE) into the acquisition extends the short-term regime to the gradient
echoes right before and after the SE; thus, doubling its duration. In addition,
it enables longer sampling with echo times between 25 ms and 80 ms so that
the fast T2 component of roughly 15 ms should become negligible [Whittall
et al., 1997; Yablonskiy et al., 2013]. For this purpose, Yablonskiy and Haacke
[1997] proposed the gradient echo sampling of spin echo (GESSE) sequence
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for qBOLD reconstructions in 1997. Here, a method was implemented that
uses GESSE data for the qBOLD and GRE data for the QSM reconstruction part
and utilises an initial low-resolution data fit instead of a straight sinus mask
and ASL acquisition for parameter initialisation. This method was compared
to the approach from Cho et al. [2018] solely relying on GRE data with re-
gard to accuracy, precision and robustness to parameter initialisation based
on simulations and seven healthy subjects. This study has been published as
Hubertus et al. [2019b].
In the second part, an artificial neural network (ANN) was used to perform
the QSM+qBOLD analysis. Today, ANNs are widely utilised in various areas
of signal processing with a focus on pattern recognition [Bishop, 1995; Nas-
rabadi, 2007], classification [Lakhani and Sundaram, 2017; Liu et al., 2018;
Zöllner et al., 2010] and general image reconstruction problems [Bollmann
et al., 2019; Yoon et al., 2018; Hammernik et al., 2018; Schnurr et al., 2019;
Maier et al., 2019; Lundervold and Lundervold, 2019]. Nonetheless, they also
allow for highly efficient and robust curve-fitting [Bishop and Roach, 1992;
Farrell et al., 1992; Hornik, 1991], which has already been exploited in poorly
conditioned problems in MRI [Bertleff et al., 2017; Domsch et al., 2018]. Dom-
sch et al. [2018] for example successfully applied an ANN for the first time to
fit the qBOLD model to GESSE data. However, the original qBOLD model imple-
mented there neglects the effects of non-blood magnetic susceptibilities. Here,
a similar approach to Domsch et al. [2018] was used; yet, QSM was inlcuded
into the ANN to obtain a QSM+qBOLD analysis for OEF quantification and it was
trained for GRE data. The performance of the ANN was then compared to the
original QSM+qBOLD approach [Cho et al., 2018] that utilises traditional quasi-
Newton (QN) methods for numerical optimisation. The comparison was done
in seven healthy subjects with regard to reconstruction speed and parameter
distribution. This study has been published as Hubertus et al. [2019c].
In the third part, QSM+qBOLD analysis was applied to the GRE data of eight
patients diagnosed with high-grade gliomas. Machine learning-based cluster-
ing was introduced as an intermediate step for the QN least-squares fitting to
further increase the robustness of the method. The oxygenation parameters
OEF, cerebral blood flow (CBF) and CMRO2 were compared between the tumour
and its contralateral side for six glioblastoma and two anaplastic astrocytoma
patients. This study has been published as Hubertus et al. [2019a].

2
B A S I C P R I N C I P L E S
This chapter gives a brief overview over the basic theoretical principles, know-
ledge of which is vital for the understanding of the subsequent work. The top-
ics range from the fundamental process of nuclear magnetic resonance over
its application in magnetic resonance imaging to the image postprocessing
technique quantitative susceptibility mapping. Moreover, physiological con-
siderations regarding tissue oxygenation and brain tumours are also covered.
2.1 nuclear magnetic resonance
In 1922, Otto Stern and Walther Gerlach discovered a new quantum mechan- The Nobel Prize
in Physics 1943:
Otto Stern "for
his contribution
to the
development of
the molecular ray
method and his
discovery of the
magnetic moment
of the proton".
ical property of electrons with their famous Stern-Gerlach experiment. They
called the phenomenon spin and although it has strong similarities to the an-
gular momentum, it is in fact intrinsic to the particle and has no analogue in
classical physics. Therefore, the total angular momentum is the sum of the
spin and the orbital angular momentum. A coupling of the electron spin with
its orbital angular momentum together with relativistic effects can explain
the splitting of energy levels in atoms, which is called the fine structure. In
1891, long before the discovery of Stern and Gerlach, Albert Abraham Michel-
son detected a further splitting of the atomic spectral lines, which is orders
of magnitude smaller. This is referred to as hyperfine structure and was ex- The Nobel Prize
in Physics 1944:
Isidor Isaac Rabi
"for his resonance
method for
recording the
magnetic
properties of
atomic nuclei".
plained only in 1924 by Wolfgang Pauli. He proposed a nuclear spin, which
is however three orders of magnitude smaller than that of the electron. Its
interaction with the magnetic field of the electrons in the atomic shell is the
main contribution to the hyperfine structure. The existence of such a nuclear
spin was verified in an experiment by Isidor Isaac Rabi, building on work of
Otto Stern, and both were awarded the Nobel Prize in Physics in 1944 and
1943 respectively. Felix Bloch [Bloch, 1946] and Edward Mills Purcell [Purcell
et al., 1946] were the first to develop methods to manipulate nuclear spins The Nobel Prize
in Physics 1952
was awarded
jointly to Felix
Bloch and
Edward Mills
Purcell "for their
development of
new methods for
nuclear magnetic
precision
measurements
and discoveries in
connection
therewith".
in solids by resonant absorption of radiofrequency fields and measured the
resulting nuclear induction. Both received the Nobel Prize in Physics in 1952
for their work on nuclear magnetic precision measurements and are regarded
as the founding fathers of nuclear magnetic resonance (NMR).
2.1.1 Nuclear Spin and Magnetic Moment
Atomic nuclei consist of so-called nucleons, which comprise protons and neut-
rons. Both particles are fermions with spin quantum number s = 1/2. Similar
to the atomic shell model, the nuclear shell model approximates the nucleus
as an harmonic oscillator with the principal quantum number n = 1, 2, 3, ...
denoting discrete energy levels. The corresponding orbital quantum number
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is given by l = n, n− 2, ... with l ≥ 0. This means that the total angular mo-Here the hat
denotes quantum
mechanical
operator
properties.
mentum of a nucleon is given by the quantum number j = |l± 1/2|. The total
angular momentum of a nucleus ~ˆI is obtained by the sum over all nucleons
and rather confusingly denoted as nuclear spin.
As an angular momentum operator, ~ˆI fulfils the commutator relations[
Iˆi, Iˆj
]
= ih¯ijk Iˆk[
Iˆi,~ˆI 2
]
= 0
(2.1)
and, therefore, common eigenvectors exist only for Iˆi and ~ˆI 2. The nuclear spin
is a discrete quantity and the eigenvalues of its magnitude and, without loss
of generality, its z-component are described by
~ˆI 2 |I, m〉 = I(I + 1)h¯2 |I, m〉
Iˆz |I, m〉 = mh¯ |I, m〉
(2.2)
with the reduced Planck’s constant
h¯ =
h
2pi
=
6.626 · 10−34 Js
2pi
(2.3)
and the nuclear spin quantum number I and magnetic quantum number m.
I can be interpreted as the shell of nuclear spin states with m describing the
spatial orientation with respect to z
I = 0,
1
2
, 1,
3
2
, ...
m = −I,−I + 1, ..., I − 1, I .
(2.4)
Without an external magnetic field, the energy of a certain quantum state is
defined only by n and I so that each state shows (2I + 1)-fold degeneration.
The nucleus of the hydrogen atom is merely a single proton, i. e. I = j = s =
1/2 holds. Hence, Iˆz has two eigenvalues with
m = ±1
2
. (2.5)
The nuclear spin is always associated with a magnetic moment ~ˆµ, which
can be expressed as multiples of the nuclear magneton
µN =
eh¯
2mp
(2.6)
with the proton charge e = 1.602 · 10−19 C and mass mp = 1.673 · 10−27 kg.
Together with the experimentally determined g-factor, the magnetic moment
of a nucleus can be calculated as
~ˆµ = γ~ˆI =
gµN
h¯
~ˆI (2.7)
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Table 2.1: Several nuclei present in the human body together with their nuclear spin
qauntum number, magnetic moment, gyromagnetic ratio divided by 2pi
and molar concentration in human grey matter as stated in Haacke et al.
[1999].
Nucleus I µ/µN γ− in MHz/T c in mol/l
1H 1/2 2.793 42.58 88 · 10 0
23Na 3/2 2.216 11.27 80 · 10−3
31P 1/2 1.131 17.25 75 · 10−3
17O 5/2 −1.893 −5.77 16 · 10−3
19F 1/2 2.672 40.08 4 · 10−6
with the gyromagnetic ratio γ. For protons, the g-factor is
gp = 5.586 (2.8)
and, hence, it follows that
γ = 2pi · γ− = 267.513 · 106 rad/s/T . (2.9)
Table 2.1 lists different nuclei that are present in the human body together
with their magnetic properties.
2.1.2 Zeeman Effect
It is common nomenclature in NMR and MRI literature to refer to the magnetic
flux density ~B as magnetic field. Let us assume there is an external magnetic xˆ, yˆ and zˆ denote
the unit vector in
each direction
and not quantum
mechanical
operators.
field that without loss of generality points in z-direction
~B0 = B0zˆ . (2.10)
In this case, the energy levels for the nuclear spin states with different m
split up and the degeneration is resolved. This phenomenon is called the
Zeeman effect and is depicted in Figure 2.1. For a proton with I = 1/2, the The terms
parallel and
anti-parallel have
to be treated with
caution as we
will discover
later.
two eigenvectors are denoted spin-up |1/2,+1/2〉 = |↑〉, where the spin is
‘parallel’ to ~B0, and spin-down |1/2,−1/2〉 = |↓〉, where the spin is ‘anti-
parallel’ to ~B0. They build an orthonormal basis of the two-dimensional (2D)
Hilbert space and
~ˆI 2 |↑〉 = 3
4
h¯2 |↑〉
~ˆI 2 |↓〉 = 3
4
h¯2 |↓〉
Iˆz |↑〉 = 12 h¯ |↑〉
Iˆz |↓〉 = −12 h¯ |↓〉
(2.11)
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E
|I, m〉
m = − 12
+ 12 h¯ω0 |↓〉
m = + 12
− 12 h¯ω0 |↑〉
~B0 = B0zˆ
Figure 2.1: Splitting of the Zeeman energy levels for a system with nuclear spin I =
1/2 and positive γ, such as a proton, when an external magnetic field
~B0 = B0zˆ is applied. The state |↓〉 increases in energy by 12 h¯ω0 and the
state |↑〉 decreases in energy by 12 h¯ω0. For the former, the spin is ‘anti-
parallel’ and for the latter, it is ‘parallel’ to ~B0.
are the eigenvalue equations. Using these eigenvectors as a basis, any nuclear
spin operator ~ˆI can be written in matrix form as
~ˆI =
h¯
2
~ˆσ (2.12)
with the Pauli matrices
σˆx =
(
0 1
1 0
)
, σˆy =
(
0 −i
i 0
)
, σˆz =
(
1 0
0 −1
)
. (2.13)
To calculate the energy of the two states, one has to define the Hamilton-
ian Hˆ. The interaction between the nuclear spin of a resting proton and a
magnetic field defined by Equation 2.10 can be described by the Hamiltonian
Hˆ = −~ˆµ · ~B = −γB0 Iˆz . (2.14)
Since the Hamiltonian is time-independent, the stationary Schrödinger equa-
tion
Hˆ |ψ〉 = E |ψ〉 (2.15)
can be used to calculate the shifts in energy level E↑ and E↓ of the two nuclear
spin states. Inserting Equation 2.14 into 2.15 yields
E↑ = − h¯2γB0
E↓ = +
h¯
2
γB0
(2.16)
and an energy difference of
∆E = h¯γB0 (2.17)
for the two states. This means that transitions between the two states are
possible by the absorption or transmission of a photon with the so-called
Larmor frequency
ω0 = γB0 . (2.18)
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mh¯√
I(I + 1)h¯
|↑〉
α
~B0 = B0zˆ
Figure 2.2: Spin-up eigenstate |↑〉 of the proton nuclear spin operators ~ˆI 2 and Iˆz
with corresponding eigenvalues. Only the squared magnitude and the z-
component of ~ˆI and not the x- and y-component can be measured sharply
at the same time as follows from Equation 2.1. α = 54.7◦.
Equation 2.18 is called the Larmor equation and describes the basic phe-
nomenon of nuclear magnetic resonance (NMR), which is also the foundation
of magnetic resonance imaging (MRI) (see Section 2.2).
2.1.3 Spin in an External Magnetic Field
The usual description of ‘parallel’ and ‘anti-parallel’ for |↑〉 and |↓〉 respec-
tively is actually misleading since, according to Equations 2.11, the eigenstates
are tilted by α ≈ 54.7◦ from the z-axis as depicted in Figure 2.2. Moreover,
quantum mechanics dictates that the nuclear spin is generally in a superpo-
sition of both the spin-up and spin-down state. Hence, it can be represented
as
|I〉 = c↑(t) |↑〉+ c↓(t) |↓〉 (2.19)
with the time-varying probability amplitudes
c↑,↓(t) = c↑,↓e−iE↑,↓t/h¯, c↑,↓ ∈ R. (2.20)
Using this general approach, the expectation values of all three components
of the nuclear spin operator can be calculated as
〈 Iˆx〉 = h¯2 〈I| σˆx |I〉 = c↑c↓h¯ cos(ω0t)
〈 Iˆy〉 = h¯2 〈I| σˆy |I〉 = −c↑c↓h¯ sin(ω0t)
〈 Iˆz〉 = h¯2 〈I| σˆz |I〉 =
h¯
2
(|c↑|2 − |c↓|2) .
(2.21)
These expectation values describe a precession of the nuclear spin vector ~ˆI
about the magnetic field (z-axis) with the Larmor frequency ω = ω0. This
motion is analogous to a gyroscope precessing about the axis of gravitation.
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2.1.4 Macroscopic Magnetisation
In NMR one usually deals with imaging volumes in the order of 1 mm3. For
water, such a volume contains approximately 6.68 · 1019 protons considering
a hydrogen nuclei density of 111 M. It is therefore sufficient to consider a
macroscopic magnetisation ~M0, defined as the density of all expectation val-
ues of the single magnetic moments ~ˆµi from N spins inside the unit volume
V
~M0 =
N
∑
i=1
〈~ˆµi〉
V
. (2.22)
Assuming that the spin system is in thermal equilibrium at temperature T
and ~B0 = B0zˆ, the magnetisation can be described as
~M0 =
N
V
γh¯
+I
∑
m=−I
pmm · zˆ (2.23)
with the population probabilities of the Zeeman levels
pm =
1
Z
e−
Em
kBT (2.24)
following a Boltzmann distribution and the state sum
Z =∑
m
e−
Em
kBT . (2.25)
Here, kB = 1.381 · 10−23 J/K denotes the Boltzmann constant. For protons, i. e.
I = 1/2, the ratio of the numbers of spins in the two possible states, parallel
(N+1/2) and anti-parallel (N−1/2), equals
N−1/2
N+1/2
=
p−1/2
p+1/2
= e−
1
2
h¯γB0
kBT · e− 12
h¯γB0
kBT = e−
h¯γB0
kBT . (2.26)
Considering the human body with a temperature of T = 310 K and the com-
monly used magnetic field strength B0 = 3 T, the population ratio is around
0.999997 meaning that the number of spins aligned with the external field ex-
ceeds the number of anti-aligned ones only by 3 parts per million (ppm). For
the population number difference ∆N, this yields
∆N = N tanh
(
1
2
h¯γB0
kBT
)
(2.27)
with the total number of states N. From the abovementioned values it follows
that h¯γB0  kBT inside the human body, and therefore the net magnetisation
can be approximated asThis is one reason
for striving
towards higher
external magnetic
fields in MRI.
~M0 = ∆N · ~µV ≈
Nh¯2γ2
4VkB
B0
T
· zˆ (2.28)
using the Taylor expansion of tanh(x) to the first order. This means that
the net magnetisation is approximately proportional to the external magnetic
field B0 and inversely proportional to the temperature T.
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2.1.5 Signal Excitation
In classical physics, a single magnetic moment ~µ inside an external magnetic
field ~B0 = B0zˆ experiences a torque that aims at aligning it with ~B0. Its equa-
tion of motion can be written as
d~µ
dt
= ~µ× γ~B0 . (2.29)
It implies that if ~µ has a component perpendicular to ~B0 (transverse compon-
ent), ~µ will start to precess about the axis of the magnetic field (z-axis) with
the Larmor frequency ω0 = γB0. This is the same motion as predicted by
quantum mechanics for a single spin (see Equation 2.21).
However, the net magnetisation ~M from the spin ensemble in thermal equi-
librium points only in z-direction with no magnetisation in the x-y-plane.
This is due to the fact that the single magnetic moments ~µi have no phase
coherence and, thus, their transverse components sum to 0. Hence, to be able
to measure any signal from the net magnetisation, ~M has to be tipped away
from ~B0. This can be realised by applying radiofrequency (RF) fields perpen-
dicular to the magnetic field axis. To properly understand their impact on the
magnetisation, one usually switches to a rotating reference frame denoted
with a prime. Generally, if one switches from a resting frame to one that ro-
tates with angular velocity ~ω, the time derivative of a function ~F transforms
to
d~F
dt
=
∂~F
∂t
+ ~ω× ~F . (2.30)
Applying this to Equation 2.29 yields
∂ ~M
∂t
= ~M× γ
(
~B0 +
~ω
γ
)
= ~M× γ~Beff
(2.31)
where the magnetisation does not precess about ~B0 any longer but rather
about an effective magnetic field ~Beff = ~B0 + ~ω/γ.
Assuming a magnetic field in z-direction ~B0 = B0zˆ and a left circularly
polarised RF field with frequency ω1 in the x-y-plane
~B1 =
 B1 cos(ω1t)−B1 sin(ω1t)
0
 (2.32)
gives
d ~M
dt
= ~M× γ(~B0 + ~B1)
= ~M× γ(B1 cos(ω1t)xˆ− B1 sin(ω1t)yˆ + B0zˆ)
(2.33)
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for the magnetisation in the resting frame. Transforming into a frame that
rotates with angular velocity −ω1 around the z-axis yields
d ~M
dt
= ~M× γ
(
B1 xˆ′ +
(
B0 − ω1
γ
)
zˆ′
)
(2.34)
= ~M× γ
(
B1 xˆ′ +
(
B0 − ω1
γ
)
zˆ
)
. (2.35)
According to this equation, the z-component of the total magnetic field will
vanish if the RF field ~B1 is applied with the Larmor frequency ω1 = ω0, leav-
ing an effective magnetic field only in xˆ′. In this case, ~M precesses about the
xˆ′-axis leading to the creation of a measurable transverse magnetisation.
By adapting the RF pulse duration τ and magnitude B1, the magnetisation
can be tipped into the transverse plane with a certain flip angle α. In general,
the flip angle can be calculated according to
α = γ
t+τ∫
t
B1(t′)dt′ . (2.36)
However, for rectangular RF pulses and small flip angles, the formula
α = γB1τ (2.37)
is also commonly utilised.
2.1.6 Relaxation and Bloch Equation
When the magnetisation is excited, i. e. tipped away from the z-axis, it can be
separated into a longitudinal component Mz and a transverse one ~M⊥. Yet,
as soon as the excitation process stops, the magnetisation relaxes back to its
original alignment as that represents the state of lowest energy. The main con-
tribution to this relaxation are dipole-dipole interactions between the nuclear
spins and the surrounding medium. These interactions can be either between
protons and protons or protons and electrons with the latter being more effec-
tive due to the stronger magnetic moment of the electron (see Equation 2.51).
The actual efficiency of the interaction depends on the relative motion of the
nuclear spins and the atoms or molecules of the medium especially on the ro-
tational motion. If the latter rotate or ‘tumble’ at the frequency ωtum, the local
dipolar field associated with them also fluctuates with ωtum. The higher ωtum,
the more ‘free’ a medium is considered (small atoms/molecules, liquids). On
the other hand, the lower ωtum, the more ‘bound’ a medium is considered
(large molecules, solids). A detailed explanantion of the physics of relaxation
in NMR is given in Bloembergen et al. [1948].
spin-lattice relaxation The relaxation of the longitudinal magneti-
sation Mz back to its initial value M0 in thermal equilibrium is owing to the
transfer of energy from the spin system to the surrounding medium in form
of heat. As the medium was commonly a solid in the early days of NMR, this
2.1 nuclear magnetic resonance 13
t
Mz
M0
T1 T1
Mz(0)
Figure 2.3: Exponential regrowth of longitudinal magnetisation Mz to initial value
M0 as described by Equation 2.39 for two different longitudinal relaxation
times T1.
is usually referred to as spin-lattice relaxation. It can be described by an ex-
ponential regrowth and is governed by the longitudinal relaxation time T1
according to
dMz
dt
=
1
T1
· (M0 −Mz) . (2.38)
A solution of this differential equation is given by
Mz(t) = Mz(0) · e−t/T1 + M0 ·
(
1− e−t/T1
)
(2.39)
with the longitudinal magnetisation immediately after the end of the RF pulse
Mz(0). An exemplary signal evolution is depicted in Figure 2.3. T1 depends
on the efficiency of the energy transport from the spin system to the lat-
tice and, therefore, differs in various materials and human tissues as can
be gathered from Table 2.2. If the tumbling rate ωtum is far away from the
Larmor frequency, i. e. off-resonant, the energy transport is inefficient. On the
other hand, a resonant ωtum leads to an efficient energy transport. The former
would result in a long T1, the latter in a short T1. The tumbling rate of freely
diffusible water, for example, is much higher than the Larmor frequency usu-
ally encountered in MRI. However, restricted water as commonly found in
biological tissue, has a lower tumbling rate closer to the Larmor frequency.
Moreover, T1 is affected by the magnetic field strength B0 as it changes the
Larmor frequency of the spins.
spin-spin relaxation The transverse magnetisation ~M⊥ = Mx xˆ + Myyˆ
also decays with time; yet, this is not due to the energy exchange with the lat-
tice but rather the dipole-dipole interaction among neighbouring spins. Due
to random fluctuations in the Brownian motion, each spin observes a slightly
different magnetic field and, thus, precession frequency. This in turn leads
to an irreversible loss of coherence and, therefore, a dephasing of the spins
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x′
y′
M⊥ x′
y′
x′
y′
t
Figure 2.4: Decay of transverse magnetisation M′⊥ = | ~M′⊥| (thick red arrow) due to
dephasing of single spins or magnetic moments (dashed red arrows). The
spins lose their coherence because each experiences a slightly different
Larmor frequency owing to microscopic inhomogeneities from Brownian
motion and dipole-dipole interactions. The dephasing is depicted in the
rotating frame of reference.
t
M⊥
T2 T2
M⊥(0)
Figure 2.5: Exponential decay of transverse magnetisation M⊥ = | ~M⊥| as described
by Equation 2.41 for two different transverse relaxation times T2.
(see Figure 2.4). Similar to the spin-lattice relaxation, this phenomenon can be
described by an exponential decay of the magnitude of the transverse mag-
netisation M⊥ = | ~M⊥| governed by the so-called spin-spin relaxation time T2.
The equation of motion in the rotating reference frame is
d ~M ′⊥
dt
= − 1
T2
· ~M ′⊥ (2.40)
with the solution
~M ′⊥(t) = ~M
′
⊥(0) · e−t/T2 . (2.41)
An exemplary signal evolution is depicted in Figure 2.5. With decreasing
ωtum, the dipolar field of the medium can be considered more and more static.
This means that nuclear spins at different positions accumulate a significantly
different phase, i. e. they loose their coherence more rapidly. With increasing
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ωtum on the other hand, neighbouring nuclear spins experience the same di-
polar field on average. Hence, T2 in more solid materials is lower than in more
liquid media. In contrast to T1 however, T2 is approximately independent of
B0 in the range of interest for NMR and MRI. T1 relaxation automatically re-
duces the coherence of the transverse magnetisation, i. e. it always entails T2
relaxation. Yet, T2 relaxation can also occur independently of T1 relaxation.
Approximate values for T2 in human tissues are given in Table 2.2
Table 2.2: Approximate longitudinal (T1) and transverse (T2) relaxation times of hy-
drogen in various human tissues at B0 = 1.5 T and body temperature
T = 310 K. Table adopted from Haacke et al. [1999].
Tissue T1 in ms T2 in ms
Grey matter (GM) 950 100
White matter (WM) 600 80
Cerebrospinal Fluid (CSF) 4500 2200
Fat 250 60
Muscle 900 50
Arterial blood 1200 200
Venous blood 1200 100
relaxation time T ∗2 The spin-spin relaxation time T2 is an intrinsic
property of the tissue. Yet, external inhomogeneities also contribute to the
dephasing of the spins and, hence, to the transverse relaxation. It is therefore
that the total transverse relaxation time T∗2 was introduced, which is defined
as
1
T∗2
=
1
T2
+
1
T′2
(2.42)
with the irreversible transverse relaxation time T2 and the reversible trans- It is common
nomenclature to
denote the
reversible
transverse
relaxation rate
with a prime.
This does not
refer to the
rotating frame of
reference here.
verse relaxation time T′2. Using the corresponding relaxation rates yields
R∗2 = R2 + R′2 . (2.43)
Real-life measurements of the transverse magnetisation in Equation 2.41 will
therefore always be governed by T∗2 and are referred to as free induction
decay (FID). The impact of T′2 however, can be removed by the utilisation of a
so-called spin echo (see Subsection 2.1.8).
bloch equations Felix Bloch derived the general equation of motion for
~M after excitation in an external magnetic field ~B in 1946. The so-called Bloch
equation is valid in homogeneous media and can be written as
d ~M
dt
= γ ~M× ~B + 1
T1
(M0 −Mz)zˆ− 1T2
~M⊥ (2.44)
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with the three components
dMx
dt
= γ
(
~M× ~B
)
x
− Mx
T2
dMy
dt
= γ
(
~M× ~B
)
y
− My
T2
dMz
dt
= γ
(
~M× ~B
)
z
− M0 −Mz
T1
.
(2.45)
In the case of ~B = B0zˆ, Equations 2.45 break down to
dMx
dt
= ω0My − MxT2
dMy
dt
= −ω0Mx − MyT2
dMz
dt
=
M0 −Mz
T1
.
(2.46)
Equation 2.39 is a solution of the z-component. The x- and y-components are
usually combined into the complex representation
M+(t) = Mx(t) + iMy(t) (2.47)
leading to the differential equation
dM+
dt
= −
(
iω0 +
1
T2
)
·M+ . (2.48)
The general solution for the complex representation is
M+(t) = M+(0) · e−i(ω0t+ϕ0)−t/T2 . (2.49)
Especially MRI is commonly only concerned with the magnitude of the NMR
signal. Hence, M+ is rewritten as
M+(t) = |M+(t)| · eiϕ(t) = M⊥(t) · eiϕ(t) (2.50)
with the magnitude
M⊥(t) = M⊥(0) · e−t/T2 (2.51)
and the phase
ϕ(t) = ω0t + ϕ(0) (2.52)
in the resting frame of reference.
2.1.7 Signal Reception
The net magnetisation ~M in thermal equilibrium points along the external
field in z-direction; however, it is orders of magnitude smaller than the ex-
ternal field (see Section 2.3). By tipping ~M into the x-y-plane, it obtains a
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transverse component M⊥ that can be easily separated from the external field.
Coils placed with their symmetry axis perpendicular to the z-axis can be uti-
lised to measure the precessing transverse magnetisation using Faraday’s Law
of Induction. This law can be derived from the fundamental Maxwell equa-
tions and states that every change of magnetic flux φ through a coil with area
~S induces a voltage in the coil according to
Uind = − ddt
∫
Scoil
~B · d~S = −dφ
dt
. (2.53)
To determine the received signal in NMR and MRI, it is convenient to con-
sider the current density~j defined as
~j(~r, t) = ~∇× ~M(~r, t) . (2.54)
The vector potential ~A from such a source current and the corresponding
magnetic field ~B can be calculated as The prime does
not refer to the
rotating frame of
reference here but
merely denotes
the integration
variable.
~A(~r) =
µ0
4pi
∫ ~j(~r)
|~r−~r ′|d
3~r ′ (2.55)
and
~B = ~∇× ~A (2.56)
with the vacuum permeability µ0 = 4pi× 10−7. Exploiting Stokes’ Theorem
gives
φ =
∫
Scoil
~B · d~S =
∮
d~l · ~A (2.57)
With the help of the vector identity ~A · (~B× ~C) = −(~A× ~C) · ~B, the magnetic
flux for a precessing magnetisation ~M can be calculated using integration by
parts
φM =
∮
d~l ·
[
µ0
4pi
∫
d3~r ′
~∇′ × ~M(~r ′)
|~r−~r ′|
]
=
µ0
4pi
∫
d3~r ′
∮
d~l ·
[(
−~∇′ 1|~r−~r ′|
)
× ~M(~r ′)
]
=
µ0
4pi
∫
d3~r ′ ~M(~r ′) ·
[
~∇′ ×
(∮ d~l
|~r−~r ′|
)]
=
∫
d3~r ′ ~M(~r ′) · ~B−(~r ′) .
(2.58)
Here, ~B−(~r) is the receive field of the coil at position ~r, which according to
the Law of Reciprocity corresponds to the magnetic field per unit current I
created by the coil at this position
~B−(~r) =
~B(~r)
I
= ~∇×
(
µ0
4pi
∮ d~l
|~r−~r ′|
)
. (2.59)
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The voltage induced into the coil from the precessing magnetisation inside
the sample is
Uind(t) = − ddt
∫
sample
d3~r ′ ~M(~r ′, t) · ~B−(~r ′) . (2.60)
As only the transverse magnetisation is of interest, the reception coils are
placed with their normal perpendicular to the main magnetic field so that
~B− ≈ ~B−⊥ . Two coupled orthogonal coils with a set 90◦ phase shift are uti-
lised to receive a complex magnetic resonance (MR) signal (Equation 2.51 and
2.52). The signal is then demodulated with a reference sine and cosine signal
oscillating at the Larmor frequency. The amplitude of the transverse magneti-
sation at t = 0 is proportional to the spin density ρ(~r) and the initial signal
phase ϕ(0) is usually set to 0. This gives
S(t) = S0 ·
∫
V
ρ(~r ′)d~r ′ · e−iγB0t · e− tT2 (2.61)
for the received NMR signal in a sample volume V. Here, S0 is the factor of pro-
portionality between the spin density and the received signal. Equation 2.61
is the basic equation for signal reception in NMR and MRI and can be used to
determine the effects of inhomogeneities in B0 for instance.
2.1.8 Spin Echo
As mentioned in Subsection 2.1.6, the transverse magnetisation decays in the
FID with the time constant T∗2 . The reversible component of the transverse sig-
nal decay has to be removed in order to obtain a tissue specific signal. This can
be achieved by applying an additional 180◦ RF pulse between the excitation
pulse and signal acquisition. Such a pulse is called refocusing pulse. When
applying the refocusing pulse at t = TE/2 after the excitation along an arbi-
trary axis in the x-y-plane, the single dephased spins are mirrored at this axis
and, thus, will be in phase again at the echo time TE. Refocusing the single
spins with such a pulse is termed spin echo. The behaviour of the magnetisa-
tion and the corresponding received NMR signal is depicted in Figure 2.6 and
Figure 2.7 respectively.
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Figure 2.6: Behaviour of the net magnetisation (red arrow) with dephasing and re-
phasing around 180◦ refocusing RF pulse applied along the x′-axis. Spin
echo, i.e. perfect rephasing of single spins, occurs at the echo time TE if
the refocusing pulse is applied at TE/2. The phenomenon is shown in the
rotating frame of reference without spin-lattice relaxation for simplicity.
Figure 2.7: RF pulse and signal decay for spin echo creation. 180◦ refocusing RF pulse
at t = TE/2 creates spin echo at echo time TE. Excitation pulse at t = 0 is
not plotted.
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2.2 magnetic resonance imaging
It took several decades until it was appreciated that the NMR phenomenon
could have a medical application with tremendous impact. In 1971 the physi-
cian Raymond V. Damadian was the first person to realise that healthy and
cancer cells had different relaxation times. With this in mind, he built the first
MR scanner and even took a whole body image in 1977. He achieved spatial
localisation by using a saddle-shaped magnetic field that was resonant only
at one voxel and by manually moving the subject within the scanner. Such a
single point imaging technique was, however, too slow for any clinical applica-
tion. To overcome this issue, the chemist Paul C. Lauterbur and the physicistThe Nobel Prize
in Physiology or
Medicine 2003:
Paul C.
Lauterbur and
Sir Peter
Mansfield "for
their discoveries
concerning
magnetic
resonance
imaging"
Sir Peter Mansfield both came up with schemes to accelerate the signal acqui-
sition for the now called magnetic resonance imaging (MRI) in 1973. Lauterbur
applied a magnetic field gradient to measure several one-dimensional (1D)
NMR signal projections and back-projected them to a 2D tomographic image.
Mansfield on the other hand proposed a linear magnetic field gradient dur-
ing excitation in order to excite the signal on a slice-by-slice basis and further
refined his approach to a line-scan technique in 1977. This line-scan method
is already very similar to today’s standard spatial encoding in MRI, which will
be covered in detail in Subsection 2.2.1. Both Paul C. Lauterbur and Sir Peter
Mansfield received the Nobel Prize in Physiology or Medicine in 2003; yet,
Raymond V. Damadian was not honoured.
2.2.1 Spatial Encoding and k-Space
To create an MR image, the NMR signal has to be localised in space. This
process is called spatial encoding and is enabled by additional magnetic field
gradients. According to Equation 2.18, the precession frequency ω of the mag-
netisation depends linearly on the external magnetic field ~B = B0zˆ. Hence, by
superimposing a linear magnetic field gradient
~G =
(
∂B0
∂x
,
∂B0
∂y
,
∂B0
∂z
)
= (Gx, Gy, Gz) (2.62)
the precession frequency becomes spatially dependent
ω(~r) = γB(~r) = γ(B0 + ~G ·~r) . (2.63)
By applying Fourier analysis to the acquired NMR signal, the spatial informa-
tion encoded in the frequency can be reconstructed. In 2D MRI three spatial
encoding steps are distinguished. They are called slice selection, frequency
encoding and phase encoding and each is applied in one spatial direction.
slice selection For slice selection, a gradient in z-direction Gz is applied
at the same time as the excitation RF pulse. This makes the precession fre-
quency dependent on the position in z
w(z) = γ(B0 + Gz · z) (2.64)
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Figure 2.8: Interplay of excitation bandwidth ∆ω, gradient in z-direction Gz and
thickness of excited slice ∆z. The larger Gz, the thinner ∆z for a given
∆ω.
and thus leaves only the magnetisation at a certain z at the resonant frequency.
If the RF pulse was of infinite length, i. e. contained a single frequency, only an
infinitesimally thin slice exactly at the resonance would be excited. However,
every excitation pulse has a certain bandwidth ∆ω due to its finite length.
Hence, the excitation takes place in a slice with thickness
∆z =
∆ω
γGz
. (2.65)
This process and the effect of Gz on the slice thickness is schematically illus-
trated in Figure 2.8.
The exact slice profile depends on the frequency distribution P(ω) of the RF
pulse, which can be easily calculated from the temporal excitation signal via
the Fourier transform. A sinc pulse is commonly applied in order to excite a
rectangular slice. Owing to time constraints the sinc pulse is, however, cut off
after several side lobes; thus, creating only imperfect slice profiles. The result-
ing slice profile for two distinct sinc pulse lengths is depicted in Figure 2.9. If
the application of Gz is centred around the RF pulse and if one assumes that
the magnetisation is flipped instantaneously at the RF peak, then the result-
ing transverse magnetisation is dephasing due to the second half of Gz. For a
gradient duration τ, the gradient moment
MG =
t+τ∫
t+ τ2
Gz(t′)dt′ (2.66)
therefore induces a distinct phase ϕ = γ ·MG · z that depends on the position
z within the slice. Hence, a so-called rephasing gradient lobe is usually ap-
plied directly after the slice selection gradient with the same gradient strength
Gz but in opposite direction and with only half the duration. This leaves the
magnetisation within the whole slice in phase. If the gradient in z is omitted
during the excitation, the magnetisation is excited independent of the posi-
tion. This approach is called global excitation and is particularly applied in
three-dimensional (3D) MRI.
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Figure 2.9: Sinc-shaped RF pulse (a) with corresponding frequency distribution P(ω)
(b). Two different durations of the RF pulse are used to calculate the fre-
quency profile with the Fourier transform. One was cut off after three
(orange), the other one after six lobes (yellow).
Figure 2.10: Schematic frequency encoding. Superimposed time signal from five dif-
ferent frequencies (left) together with corresponding Fourier transform
(FT). The Fourier transform reconstructs the amplitudes of the single fre-
quency components, which can then be located on the x-axis according
to Equation 2.67.
frequency encoding The slice selection reduces the spatial encoding
to a 2D problem. The NMR signal in one dimension can be easily localised by
again applying a linear magnetic field gradient, e. g. Gx in x-direction, but this
time during the readout of the signal. This makes the precession frequency of
the magnetisation dependent on the spatial position x according to
ω(x) = γ(B0 + Gx · x) . (2.67)
Hence, the received signal is a combination of single signals with different
frequencies. By applying a 1D Fourier transform, the amplitudes of each sig-
nal frequency can be recovered. These frequency amplitudes can then be as-
signed to the positions along the x-axis where they originated from according
to Equation 2.67 (Figure 2.10). It is therefore that this localisation is called fre-
quency encoding. When the gradient Gx is applied for a time τx, the transverse
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magnetisation acquires an additional time-dependent phase and thus the re-
ceived MR signal can be calculated via
S(t, Gx) = S(t)
∫
e
−iγ
t∫
0
Gx(t′)xdt′
dx (2.68)
with S(t) given by Equation 2.61.
phase encoding Even with frequency encoding along the x-axis, the de-
tected signal amplitude is still only a projection along the y-axis. However,
simultaneous frequency encoding in x- and y-direction is not possible as the
received signal will always be only a projection perpendicular to the total ap-
plied gradient. Hence, the magnetisation along the y-axis has to be encoded
before the actual readout of the signal. This is achieved by applying a gradi-
ent Gy in y-direction for a duration τy between signal excitation and reception.
During that time the magnetisation along y precesses at different frequencies,
resulting in a distinct phase at the signal readout, which depends on the y-
position. This means that the acquired signal is a superposition of separate
signals along y that have the same frequency but not phase. If this step is
repeated N times while Gy is incremented from −Gy,max to Gy,max, there are
N signal measurements, each consisting of a different superposition of single
signals with different phases along the y-axis. The position in y of N signal
amplitudes can then be calculated from this set of linear equations. Analog-
ous to Equation 2.68, the received NMR signal can be expressed as
S(t, τy, Gy) = S(t)
∫
e
−iγ
τy∫
0
Gy(t′)ydt′
dy . (2.69)
Despite the similarity of Equation 2.68 and 2.69, this approach for spatial
localisation is referred to as phase encoding since the frequencies along the
y-axis are all the same during readout. This is also why the phase has no
explicit time dependency.
In 3D MRI no slice selection is performed but rather phase encoding is ap-
plied both in y- and z-direction.
k-space Assuming a rephased excited slice of thickness ∆z and neglecting
relaxation effects in Equation 2.68 and 2.69, the total received signal in 2D MRI
(compare to Equation 2.61) can be written as
S(t, ~G) = S0
∫ ∫
ρ(x, y)e
−iγ
(
t∫
0
Gx(t′)xdt′+
t∫
0
Gy(t′)ydt′
)
dxdy . (2.70)
The integrals in the exponent correspond to a wave number k, which can be
defined according to
kx =
γ
2pi
∫ t
0
Gx(t′)dt′
ky =
γ
2pi
∫ t
0
Gy(t′)dt′ .
(2.71)
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This simplifies Equation 2.70 to
S(~k) = S0
∫ ∫
ρ(x, y)e−i(2pikx ·x+2piky·y)dxdy
= S0
∫
ρ(~r)e−2pii~k·~rd2~r
= S0 · (Fρ) (~r)
(2.72)
with the Fourier transform F and an implicit time dependence of the signal
S(~k) = S(~k(t)). Equation 2.72 can be interpreted as sampling spatial frequen-
cies ~k in Fourier space, which is usually referred to as k-space in MRI. By
changing the gradient moment (Equation 2.66), different wave numbers can
be reached, i. e. different points in k-space can be sampled. The actual trans-
verse magnetisation, i. e. the complex MR image, can be retrieved from S(~k)
by applying an inverse Fourier transform
M⊥(~r) = S0 · ρ(~r) =
∫
S(~k)e2pii~k·~rd2~k . (2.73)
In practice, S(~k) is measured discretely for different~k by adapting the gradi-
ent moments and RF pulses in order to follow a certain k-space trajectory.
So-called sequence diagrams can be used to visualise and facilitate the un-
derstanding of these trajectories with three examples being presented in Sub-
section 2.2.3 (Figure 2.13, 2.14 and 2.15). The effects of the discrete signal
sampling on the resulting image parameters will be covered in the following
Subsection 2.2.2.
2.2.2 Discrete Data Sampling and Image Parameters
In Equation 2.72 and 2.73, it is assumed that the signal is sampled continu-
ously throughout the whole k-space; however, this is not feasible in practice.
The most common sampling technique is Cartesian with k-space increments
∆kx in frequency encoding and ∆ky in phase encoding direction. For fre-
quency encoding, a constant gradient Gx is applied for a time tx and only
Nx data points with a time increment of ∆tx = txNx are sampled by an ana-
logue to digital converter (ADC). For phase encoding, the gradient is applied
for a constant time ty but with varying amplitude from −Gy,max to Gy,max in
Ny steps of increment ∆Gy =
2Gy,max
Ny . This yields
∆kx =
γ
2pi
Gx∆tx (2.74)
∆ky =
γ
2pi
∆Gyty . (2.75)
To take into account the discrete sampling of k-space and to study the result-
ing effects on the image parameters, one can multiply the k-space signal S(~k)
with a 2D sampling function, the so-called Dirac comb or Shah function X,
which is defined as
1X∆kx(kx) =
∞
∑
l=−∞
δ(kx − l∆kx) (2.76)
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Figure 2.11: One-dimensional Dirac comb or Shah function in k-space (left) and
spatial domain (right) representing discrete and equally distributed
sampling using delta distributions.
in 1D and as
2X∆kx,y(kx, ky) =
1X∆kx(kx) · 1X∆ky(ky) (2.77)
in 2D. This function represents the discrete sampling in k-space by a sequence
of Dirac delta distributions with distance ∆k and a schematic drawing of the
1D case is depicted in Figure 2.11. For simplicity, it is still assumed that an
infinite amount of samples is acquired. The discretely sampled signal in k-
space can thus be written as
Ss(~k) = S(~k) · 2X∆kx,y(kx, ky) (2.78)
According to the convolution theorem, the multiplication of S(~k) and 2X(~k)
in k-space leads to a convolution (∗) of the inverse Fourier transforms in
image space. The inverse Fourier transform of X in 1D is also given by a
Dirac delta comb(
F−1 1X∆kx
)
(x) =
1
∆kx
1X 1
∆kx
(x)
=
1
∆kx
∞
∑
m=−∞
δ
(
x− m
∆kx
)
.
(2.79)
Hence, the resulting transverse magnetisation in image space is calculated
according to
Ms⊥(~r) =
(
F−1Ss
)
(~r)
=
(
F−1S
)
(~r) ∗
(
F−1 2X∆kx,y
)
(~r)
= M⊥(~r) ∗ 1∆kx
∞
∑
m=−∞
δ
(
x− m
∆kx
)
∗ 1
∆ky
∞
∑
n=−∞
δ
(
y− n
∆ky
)
=
1
∆kx∆ky
∞
∑
m,n=−∞
M⊥
(
m
∆kx
,
n
∆ky
)
.
(2.80)
According to Equation 2.78, all sampled spatial frequencies are integer mul-
tiples of the k-space increments ∆kx and ∆ky. This means, however, that the
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Figure 2.12: Discrete k-space sampling (left) and corresponding image (right) con-
nected by a discrete Fourier transform (FT) (a). Larger increments ∆k in
phase encoding direction lead to a smaller field of view (FOV), which
can result in wrapping artefacts (b). The resolution is defined by the
maximum k reached and thus the same in both cases.
signal in image space will be periodic with 1∆k . Hence, the so-called field of
view (FOV) is defined as
FOVx =
1
∆kx
(2.81)
FOVy =
1
∆ky
. (2.82)
The increments in k-space have to be chosen such that the resulting FOV
covers the whole object. Parts of the object that are outside the FOV will wrap
back into the opposite side otherwise (Figure 2.12) due to the periodicity. This
artefact is known as aliasing. Owing to the properties of the discrete Fourier
transform, the signal in image space also consists of Nx × Ny pixels. The
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distance between the pixels and thus the in-plane spatial resolution of the MR
image can be calculated as
∆x =
FOVx
Nx
=
1
γGx∆tx Nx
(2.83)
∆y =
FOVy
Ny
=
1
γ∆GytyNy
. (2.84)
Increasing the gradient strength or duration while keeping the number of
sample points constant will increase the resolution in frequency encoding
direction by decreasing the FOV. The same holds true for the gradient incre-
ments and duration in phase encoding direction. Taking into account Equa-
tions 2.74, 2.75 and 2.81, 2.82, one can determine the sampling requirements
∆tx ≤ 1
γGx Nx∆x
(2.85)
∆Gy ≤ 1
γtyNy∆y
. (2.86)
Equation 2.85 and 2.86 represent the Nyquist sampling theorem for MRI stat-
ing that the frequency of the signal sampling must be at least twice the max-
imum occurring frequency in order to be able to exactly reconstruct the signal.
Another important image parameter in MRI is the so-called signal to noise
ratio (SNR). It is commonly defined as the ratio of the mean signal within
a voxel containing tissue and the standard deviation of the signal within a
voxel containing no tissue and thus only noise. Sufficient SNR in an MR im-
age is mandatory for further processing and in order to draw any medical
conclusion from it. The SNR can be increased for instance by either acquiring
Nacq single acquisitions and averaging them or by increasing the voxel size
V = ∆x · ∆y · ∆z
SNR ∝
√
Nacq ·V . (2.87)
2.2.3 Imaging Sequences
spin echo sequences The sequence diagram of a 2D spin echo sequence
together with the corresponding k-space trajectory is depicted in Figure 2.13.
After the slice selective excitation using a 90◦ RF pulse and a concurrent slice
selection gradient in z-direction (I), the transverse signal is in phase and, thus,
in the centre of k-space. It can be approximated that the spins flip instanta-
neously in the middle of the RF pulse leading to a dephasing of spins along
the z-direction inside the excited slice in the second half of the slice selec-
tion gradient. An additional gradient in z-direction with the opposite sign
and half the moment of the slice selection gradient is sufficient to rephase
theses spins again. After that, a positive dephasing gradient in x and a posi-
tive phase encoding gradient in y-direction are applied moving to the upper
right corner of k-space (II). A 180◦ refocusing RF pulse that is simultaneously
28 basic principles
Figure 2.13: 2D spin echo sequence diagram and k-space trajectory.
applied with yet another slice selective gradient at t = TE/2 flips the mag-
netisation inside the excited slice yielding a reflection at the centre of k-space
(III). No rephasing gradient in z-direction is necessary in this case as the 180◦
flip in the middle of the RF pulse has the same effect as changing the sign
of the slice selective gradient. A positive readout gradient in x-direction to-
gether with the actual readout by an ADC with its centre at t = TE leads to
the sampling of the spin echo by acquiring a full line in k-space (IV). After
the so-called repetition time TR, the whole process is repeated with a reduced
phase encoding gradient in y-direction until the desired amount of k-space is
sampled.
Figure 2.14: 2D gradient echo sequence diagram and k-space trajectory.
gradient echo sequences The sequence diagram of a 2D gradient echo
sequence together with the corresponding k-space trajectory is illustrated in
Figure 2.14. In contrast to a spin echo sequence, the magnetisation is initially
flipped by an angle α ≤ 90◦ and the dephasing gradient in x is applied with
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Figure 2.15: 2D echo-planar imaging sequence diagram and k-space trajectory.
the opposite sign moving to the upper left corner of k-space instead. Without Jens Frahm won
the European
Inventor Award
in 2018 for the
development and
his further work
on gradient echo
sequences [Haase
et al., 1986] that
paved the way for
accelerated MRI.
any intermediate refocusing pulse, the gradient echo is read at t = TE with
the same readout gradient and ADC sampling a full line of k-space. Likewise,
the whole procedure is repeated after one TR. Yet, omitting the refocusing
pulse and having lower flip angles allows for much shorter repetition times.
For short TR, it is possible that not all the magnetisation relaxes back into
thermal equilibrium. The remaining transverse magnetisation can either be re-
wound, i. e. all applied gradients are reversed, thus moving back to the centre
of k-space, or spoiled, i. e. strong gradients are applied in x- and y-direction
in order to maximally dephase the remaining transverse magnetisation. The
flip angle α has to be chosen appropriately in order to maximize the signal
after repeated excitation and relaxation during TR. For spoiled gradient echo
sequences, the flip angle that gives maximum signal for a tissue with longitu-
dinal relaxation time T1 is given by the Ernst angle
αE = arccos
(
e−
TR
T1
)
. (2.88)
By choosing short repetition times with the corresponding Ernst angles, the
gradient echo sequence allows sampling k-space with much higher efficiency
leading to shorter scan times or higher resolution images.
echo planar imaging sequences If even shorter acquisition times are
needed, echo-planar imaging (EPI) sequences can be utilised (Figure 2.15).
Negative gradients are applied in x- and y-direction after excitation and slice
selection in order to jump to the lower left corner of k-space (I and II). Then,
a gradient echo is acquired by applying a strong positive readout gradient in
x and sampling one line in k-space with the ADC (II). After that, a small pos-
itive phase encoding gradient, a so-called ‘blip’ (IV) is applied in y-direction
to jump to the next higher line in k-space. This line is read again with an ADC
and readout gradient in x, the latter having a negative sign this time how-
ever. This succession of readout gradients with alternating signs and phase
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encoding blips is applied in such a rapid fashion that the whole k-space can
be sampled after only one excitation. This sampling technique requires fast
switching of strong gradients and, thus, is rather demanding for the hardware
and also prone to artefacts. Yet, it enables fast image acquisition mandatory
for applications, such as functional magnetic resonance imaging (fMRI).
2.2.4 Image Contrasts
MRI is a powerful imaging modality due to its strong soft tissue contrast.
Generally, this contrast is caused by differences in the relaxation times T1, T2
and the proton density (PD). The contribution of one single parameter to the
observed contrast, however, can be manipulated by choosing the sequence
parameters appropriately. For instance, by selecting short TE, the transverse
magnetisation does not have much time to dephase before the signal is ac-
quired, thus, limiting the contrast owing to T2 (compare to Figure 2.5). LongShort and long
TR and TE are
always with
regard to the
corresponding
relaxation times
T1 and T2.
TR on the other hand allows the longitudinal magnetisation to fully relax
back to equilibrium yielding the same signal magnitude for subsequent ex-
citations independent of T1 (compare to Figure 2.3). It is therefore that short
TE and TR generally promote T1 contrast, i. e. the image would be called T1-
weighted, whereas long TE and TR promote T2 contrast, i. e. the image would
be called T2-weighted. A combination of short TE and long TR suppresses
contrast owing to relaxation times leaving the fundamental proton density as
the only difference, which yields a PD-weighted image. Long TE and short
TR does not generate any physiological contrast. Optimal contrast is achieved
when TE and TR are in the order of T2 and T1 respectively. Figure 2.16 shows
an exemplary brain slice from a spin echo sequence depicting the three dis-
tinct contrasts together with the corresponding TR and TE. Tissues with long
T1 and T2, such as cerebrospinal fluid (CSF), generally appear darker on T1-
weighted and brighter on T2-weighted images. T1-weighting is usually pre-
ferred for imaging of the anatomy whereas T2-weighting is advantageous for
pathology as it is more sensitive to oedema.
2.2.5 Dynamic Contrast Enhanced Imaging
Dynamic contrast enhanced (DCE) imaging is a technique that measures time-
resolved T1-weighted MR images during the pass of an injection of a gadolini-
um-based contrast agent. It allows to infer information about haemodynamic
parameters, such as the blood flow or volume, from the temporal evolution
of the signal magnitude S(t) in every voxel. The analysis of DCE data consists
of two distinct steps: First, the concentration of the contrast agent over time
c(t) has to be derived from S(t) and second, tracer-kinetic theory has to be
applied to c(t) in order to quantify haemodynamic parameters.
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Figure 2.16: Exemplary sagittal brain slice from a spin echo sequence depicting a T1-
T2- and PD-weighted image together with the corresponding TR and TE.
One possibility to estimate c(t) is to use the relative signal enhancement,
i. e. to normalise the signal to the baseline before contrast agent injection S0
according to
c(t) =
R10
r1
S(t)− S0
S0
. (2.89)
Here, R10 is the longitudinal relaxation rate of the tissue prior to the injection
of contrast agent and r1 is the relaxivity of the contrast agent itself. However,
this approach assumes that the signal is always linear with the concentration
of contrast agent, which is not necessarily given.
With respect to tracer-kinetic theory, all DCE approaches assume linear and
stationary systems [Sourbron and Buckley, 2011]. This means that the tissue
concentration ct(t) is proportional to the convolution of a residue function
R(t) and the concentration in an artery ca(t) supplying blood to the region of
interest (ROI)
ct(t) = fp · R(t) ∗ ca(t) . (2.90)
The factor of proportionality fp is the plasma flow carrying contrast agent
into the ROI and ca(t) is usually called the arterial input function (AIF). fp can
be directly inferred from Equation 2.90 by deconvolution; yet, by applying
tracer-kinetic modelling, additional haemodynamic parameters can be recon-
structed from the temporal evolution of R(t). A good overview of different
models and general DCE is given by Sourbron and Buckley [2011] and Ingrisch
and Sourbron [2013].
2.2.6 Arterial Spin Labelling
Arterial spin labelling (ASL) is a non-invasive MRI technique to measure tissue
perfusion using the water in arterial blood itself as an endogenous and freely-
diffusible tracer. The method and similar concepts were proposed by Detre
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Figure 2.17: Schematic process of arterial spin labelling in the brain. The magneti-
sation of the inflowing arterial blood is inverted prior to imaging for
the ‘tag’ image whereas it is left untouched for the ‘control’ image. The
difference image ∆M = tag− control is perfusion-weighted.
et al. [1992], Williams et al. [1992] and Kwong et al. [1992] in 1992. The general
concept of ASL is that two images are acquired, one ‘tag’ and one ‘control’
image. For the ‘tag’ image, incoming arterial blood is labelled proximal toRecently, ASL has
been brought
more and more
into focus owing
to the findings
that some
gadolinium-based
MR contrast
agents revealed
significant tissue
accumulation
[Ramalho et al.,
2016].
the tissue of interest first, usually by inverting the magnetisation. Then the
image is acquired after allowing the labelled blood water to travel from the
labelling to the imaging site and exchange with the tissue water during the so-
called post-labelling delay (PLD). Caution has to be exerted to label the blood
water in vessels that actually feed the tissue that is being imaged. The ‘control’
image is a mere image without any preparation of magnetisation. Assuming
that the static components are the same in both images, the difference image
∆M = tag − control is a measure of the tissue perfusion, thus also called
perfusion-weighted. The process is shown schematically in Figure 2.17 for an
application in the brain. One major issue in ASL is that the perfusion signal
makes up only approximately 1% of the total tissue signal leaving the ∆M
image with very poor SNR. Hence, several pairs of ‘tag’ and ‘control’ image
are usually acquired and averaged for ASL.
The readout of the actual images can be chosen freely, for example a 3D-EPI;
however, three types of ASL are commonly distinguished depending on their
approach for labelling the blood water (see Figure 2.18).
continuous arterial spin labelling The ASL method originally
proposed by Detre et al. [1992] and Williams et al. [1992] employs a con-
tinuous RF irradiation proximal to the imaging FOV for labelling, hence it is
called continuous arterial spin labelling (CASL). When a magnetic field gradi-
ent is simultaneously applied along the flow direction of the arterial blood,
the magnetisation experiences a slow variation of resonance frequency lead-
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Figure 2.18: Different labelling techniques as applied in continuous arterial spin la-
belling (CASL), pulsed arterial spin labelling (PASL) and pseudocontinu-
ous arterial spin labelling (pCASL). CASL uses continuous RF irradiation
labelling the magnetisation in a thin slice by flow-driven adiabatic in-
version. PASL utilises a short 180◦ RF pulse to invert the magnetisation
inside a thick slab. pCASL employs flow-driven adiabatic inversion in a
thin slice similar to CASL; however, it mimics the effect of continuous
RF irradiation by a train of very short pulses. The labelling volume is
depicted in yellow, the imaging volume is depicted in orange.
ing to an effective inversion while the blood flows through the thin labelling
slice. The RF irradiation is typically kept up 2-4 s for this so-called flow-driven
adiabatic inversion.
pulsed arterial spin labelling The longer the RF irradiation, the
more energy is deposited in the tissue. Moreover, the RF hardware is not op-
timised for continuous but rather pulsed irradiation. Hence, Edelman et al.
[1994] proposed to use a short (10-20 ms) 180◦ RF pulse to invert the magneti-
sation of the blood water inside a thick slab proximal to the imaging volume.
This so-called pulsed arterial spin labelling (PASL), has higher labelling effi-
ciency, however, it suffers from strongly varying arrival times of the labelled
blood in the imaging volume due to the thick labelling slab. This leads to a
varying amount of T1 relaxation and, thus, introduces a bias into the perfu-
sion estimates.
pseudocontinuous arterial spin labelling To exploit the advan-
tages of both techniques, Wu et al. [2007] and Dai et al. [2008] proposed to
combine CASL and PASL by using a flow-driven adiabatic inversion inside a
thin labelling slice, yet, employing a train of very short (≈ 1 ms) RF pulses.
This approach is called pseudocontinuous arterial spin labelling (pCASL).
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If the difference image ∆M is corrected for biases, for instance from T1
relaxation, and referenced to a PD-weighted image, the actual perfusion val-
ues can be quantified. The perfusion parameter in the brain is called cerebral
blood flow (CBF) and usually given in ml/100 g/min, i. e. referenced to 100 g
tissue. Typical values are in the order of 60 ml/100 g/min in grey matter and
20 ml/100 g/min in white matter [Günther et al., 2005]. A good overview
of perfusion quantification using ASL is given by the consensus paper from
Alsop et al. [2015].
2.3 magnetic susceptibility
The volume magnetic susceptibility of a material describes its capability to be-
come macroscopically magnetised in an external magnetic field with strength
~H. In general, it can be defined as a tensor of rank 2 with the following equa-
tion
~M = χV,m(~H)~H (2.91)
where ~M is the magnetisation. The indices are sometimes stated to distin-
guish it from the molar and mass magnetic susceptibility as well as from the
electric susceptibility; however, they will be omitted from now on. In most ma-
terials, especially in human tissue, the magnetic susceptibility is independent
of the applied magnetic field strength. Furthermore, most of the human tis-
sues can be approximated as isotropic, which leaves us with a scalar magnetic
susceptibility and the linear relationship
~M = χ~H . (2.92)
For the magnetic flux density ~B, this means
~B = µ0(~H + ~M)
= µ0
1+ χ
χ
~M(χ)
(2.93)
with the vacuum permeability µ0 = 4pi · 10−7.
χ is a dimensionless quantity and can range from −1 to infinity. This is,
however, only true in the international system of units (SI) since χ has to be di-
vided by a factor of 4pi if one switches to the still often used centimetre-gram-
second (cgs) system. Materials are generally divided into three categories: dia-
magnetic (χ < 0), paramagnetic (χ > 0) and ferromagnetic (χ  0). In the
special case of χ = −1, any external magnetic field is perfectly compensated
inside the material, thus, the substance is superconductive. Water and, hence,
also human tissue is slightly diamagnetic with χ only in the range of −10−6.
Because of this, χ is often stated in parts per million (ppm). Although there
are also para- and ferromagnetic materials in the body, especially iron, their
concentration is always so low that all human tissues have a negative suscep-
tibility. It is therefore that tissue susceptibility is often given relative to χwater,
i. e. it is said to be either more dia- or paramagnetic than water. Table 2.3
shows the absolute magnetic susceptibility of different materials.
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Table 2.3: Volume magnetic susceptibilities in SI units of different materials taken
from Schenck [1996] and Jain et al. [2012].
Material χ in ppm
Bismuth −164
Fully oxygenated blood −9.15
Water† −9.05
Magnesium 11.7
Stainless steel 3520− 6700
(non-magnetic, austentic)
† For T = 37◦ C, ρ = 993.3 kg/m3, mmol = 18.015 g/mol
2.3.1 Lorentz Approach
Assuming a static external field ~Bext(~r) = ~B0 +~Binhom of an MRI scanner, which
itself already consists of the static homogeneous main field ~B0 and the static
hardware-related inhomogeneous field ~Binhom. If a material with a certain χ
is placed in ~Bext(~r), it will become magnetised and, thus, create an additional
perturbation or demagnetisation field ~Bp(~r). This perturbation is mainly gen-
erated by the magnetic field of the moving electrons in the atoms of the mater-
ial, neglecting the contribution of the nucleus. Using the first non-zero term
of the multipole expansion yields a dipole field
~bp(~r, ~m) = µ0 ·

3rˆ(~m·rˆ)−~m
4pi||~r||32
,~r 6= 0
2
3~m ,~r = 0
(2.94)
with the unit vector rˆ in the direction ~r and the magnetic moment of the
electron ~m.
Assuming that the field is observed at a point ~r that is far away from the
atom itself compared to its spatial extent, a dipole approximation can be
used, which states that the macroscopic perturbation field can be calculated
by merely summing over all dipole moments ~mi at positions~ri
~Bp(~r) =∑
i
~bp(~r−~ri, ~mi) ,~r 6=~ri . (2.95)
When dealing with macroscopic samples like in MRI, however, carrying out
this summation is generally not practicable. To circumvent this issue, the
Lorentz approach can be applied, which divides the area around ~r into a
near region Vnear and distant region Vdist. In the near region Vnear, the mag-
netic moments are considered discrete and, thus, the summation has to be
conducted. In Vdist on the other hand, the magnetic moments become con-
tinuous and, hence, can be represented by a magnetic moment density, i. e.
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magnetisation ~M(~r). This simplifies the summation process to an integration.
Taking this into account, the overall magnetic field may be written as
~B(~r) = ~Bext(~r) +∑
d
~bp(~r−~rd, ~md)
= ~Bext(~r) + µ0
∫
Vdist(~r)
〈
∑
i
3lˆ(mˆi · lˆ)− mˆi
4pi||~r−~r ′||32
||~mi||2δ(~r ′ −~ri)
〉
d3~r ′
+∑
j
~bp(~r−~rj, ~mj)
= ~Bext(~r) + µ0
∫
Vdist(~r)
3lˆ(Mˆ(~r ′) · lˆ)− Mˆ(~r ′)
4pi||~r−~r ′||32
|| ~M(~r ′)||2 d3~r ′
+ ~Bnear(~r)
= ~Bext(~r) + ~Bdist(~r) + ~Bnear(~r)
(2.96)
with the unit vector lˆ pointing along~r−~r ′ and Dirac’s delta distribution δ(~r).Again, the prime
does not refer to
the rotating
frame of reference
here but merely
denotes the
integration
variable.
Here, i is summed for all ~ri ∈ Vdist and j for all ~rj ∈ Vnear. The brackets
〈〉 shall denote the proper averaging process that is necessary to obtain the
macroscopic magnetisation ~M(~r) from the microscopic magnetic moments
~mi, which is explained in Hu [2000]. One has to bear in mind that the mag-
netic field is not only determined by the distribution of the single magnetic
moments but also by the chemical environment of the atoms and molecules
themselves. It is therefore that additional parameters, such as magnetic shield-
ing of the electron shell and paramagnetic effects of second order, can be
incorporated into the so-called chemical shift σ, leading to
~B(~r) = (1− σ) ·
(
~Bext(~r) + ~Bdist(~r) + ~Bnear(~r)
)
. (2.97)
In MRI, it is known that the chemical shift plays a significant role only in fat
tissue and, hence, is usually neglected in brain imaging, for example. The
form of Vnear can be chosen arbitrarily as long as its size still allows the as-
sumption of a magnetic moment density in Vdist. Generally, it is said that the
size should be microscopically large but macroscopically small. Assuming
that ~Bext(~r) = Bextzˆ and |χ|  1 as it is common in MRI, a first-order approx-
imation of Equation 2.93 can be used for the distance field in Equation 2.96
Bdist(~r) = Bext(~r)
∫
Vdist(~r)
χapp(~r ′) · bχ(~r−~r ′)d3~r ′ (2.98)
with the macroscopic unit dipole function
bχ(~r) =
3rˆ(zˆ · rˆ)− zˆ
4pi||~r||32
· zˆ = 3 cos
2 θ− 1
4pi||~r||32
,~r 6= 0 (2.99)
and the apparent magnetic susceptibility
χapp = zˆT · χ · zˆ . (2.100)
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By redefining the macroscopic unit-dipole function to
b˘χ(~r) =
bχ(~r) ,~r 6= 0b˘χ,0 ,~r = 0 (2.101)
and extending the integral in Equation 2.98 to the full space, one obtains a
convolution integral describing the classical macroscopic field and a compen-
sation integral over Vnear
Bdist(~r) = Bext(~r)
 ∫ χapp(~r ′) · b˘χ(~r−~r ′)d3~r ′
−
∫
Vnear(~r)
χapp(~r ′) · b˘χ(~r−~r ′)d3~r ′
 .
(2.102)
The actual value of the dipole function at ~r = 0 is not important for Bdist(~r)
as it is present in both integrals. Assuming that the variation of χapp(~r) is
negligible within Vnear, gives
B(~r) = Bext(~r) + Bext(~r) · {χapp(~r) ∗ b˘χ(~r)}
+
Bnear(~r)− Bext · χapp ∫
Vnear(~r)
b˘χ(~r−~r ′)d3~r ′
 (2.103)
for the total field with the 3D convolution operator ∗.
A further approximation, which is commonly used in MRI, is that the mag-
netic moments are randomly distributed. In this case, the summation over
all dipoles inside Vnear and, hence, ~Bnear equals 0 when Vnear is spherical
(Lorentz sphere). This approximation is reasonable in most tissues; yet, it
does not necessarily hold in highly anisotropic tissues, such as brain white
matter. However, the near field also vanishes in the case of random Brownian
motion of the hydrogen nuclei within a steadfast distribution of dipoles [Dur-
rant et al., 2003]. Assuming a Lorentz sphere and exploiting the mean-value
theorem of harmonic functions [Hu, 2000] simplifies the rightmost integral in
Equation 2.103 to ∫
Vnear(~r)
b˘χ(~r−~r ′)d3~r ′ = b˘χ,0 . (2.104)
As mentioned before, b˘χ,0 can be chosen arbitrarily without affecting B(~r) and,
thus, one obtains the source to field equation
B(~r) = Bext(~r) + Bext(~r) · {χapp(~r) ∗ b˘χ(~r)} (2.105)
by setting b˘χ,0 = 0.
38 basic principles
2.4 tissue oxygenation
The main amount of energy created inside living cells at rest is due to the
oxidation of glucose as part of the aerobic metabolism according to
C6H12O6 + 6 O2 → 6 CO2 + 6 H2O+ ∆E . (2.106)
Especially brain tissue needs a constant amount of oxygen to work properly, a
phenomenon called autoregulation. Both the delivery of oxygen and glucose
and other nutrients to the tissue and the removal of the metabolic waste, such
as CO2, is executed by the blood.
2.4.1 Properties of Blood
Human blood comprises blood cells that are suspended in a liquid phase
called blood plasma. Blood plasma makes up approximately 55 % of theThe affinity of
binding oxygen
depends inversely
on the blood
acidity and CO2
concentration.
This is known as
the Bohr effect.
total blood volume and consists, apart from proteins and dissolved glucose,
hormones, mineral ions and carbon dioxide for example, mainly of water
(≈ 90 %). The blood cells on the other hand are subdivided into red (erythro-
cytes) and white blood cells (leukocytes) as well as platelets (thrombocytes).
The platelets play a vital role in the clotting of blood and the main function
of the white blood cells is the immune defence. The red blood cells make up
the largest part (≈ 96 %) of blood cells and mainly function as carrier for oxy-
gen. The volume fraction of the red blood cells with regard to the total bloodAfter binding the
first O2 molecule,
the haemoglobin
undergoes
conformational
changes, making
the subsequent
oxygen binding
easier.
volume is called haematocrit (Hct) and is usually around 45 % in healthy hu-
mans though the exact number varies from person to person and depends
on gender and other factors. Red blood cells mainly consist of haemoglobin,
a molecule that itself comprises four metalloproteins as subunits. These sub-
units have the coordination complex haem, which is built around a central
Fe2+ ion, as a prosthetic group. Each Fe2+ can bind one O2 molecule as ad-
ditional ligand allowing a maximum of four O2 molecules per haemoglobin.
The oxygen-bound state is referred to as oxyhaemoglobin (HbO2) whereas the
unbound state is called deoxyhaemoglobin (Hb). The oxygen saturation of the
blood Y is defined as the relative concentration of HbO2 with regard to the
total haemoglobin concentration
Y =
[HbO2]
[HbO2] + [Hb]
. (2.107)
One usually distinguishes between arterial and venous oxygen saturation de-
noted as Ya and Yv or SaO2 and SvO2 respectively.
Furthermore, binding oxygen alters the magnetic properties of the iron
ion in haemoglobin. Free Fe2+ has six valence electrons distributed across
five 3d-orbitals leaving four electrons unpaired. These five energy levels are,
however, degenerated. In deoxyhaemoglobin, Fe2+ experiences a weak ligand
field leading to a splitting into three lower and two higher energy levels. Yet,
it remains energetically favourable for the electrons to stay unpaired. Only
when oxygen is bound in oxyhaemoglobin, the energy difference due to the
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Figure 2.19: Free Fe2+ ions have six valence electrons distributed across five d-
orbitals. These energy states are degenerated without external ligand
field. The weak ligand field present in deoxyhaemoglobin (Hb) leads to
a splitting into two higher and three lower energy states. However, it
is still favourable to keep four unpaired electrons maintaining the total
spin quantum number S = 2. Only in the strong ligand field present
for oxyhaemoglobin (HbO2), the splitting becomes large enough for the
two higher energy electrons to pair with the lower energy ones yielding
S = 0. Hence, Hb is paramagnetic whereas HbO2 is diamagnetic.
now strong ligand field becomes high enough for the electrons inside the
two higher energy levels to fall down and pair with the lower energy level
ones. Hence, the paramagnetic deoxyhaemoglobin with total spin quantum
number S = 2 turns into the diamagnetic oxyhaemoglobin with S = 0 (see
Figure 2.19). This difference in magnetic susceptibility between Hb and HbO2
is the reason for the blood oxygenation level-dependent (BOLD) effect, which
is the basis of fMRI for instance.
Assuming that only red blood cells (χrbc) and plasma (χplasma) have signif-
icant contributions, the macroscopic magnetic susceptibility of blood can be
calculated according to Weisskoff and Kiihne [1992]
χblood = Hct · χrbc + (1−Hct) · χplasma . (2.108)
The magnetic susceptibility of the red blood cells has a contribution from
both fully oxygenated (χoxy) and deoxygenated erythrocytes (χdeoxy)
χrbc = Y · χoxy + (1−Y) · χdeoxy . (2.109)
Combining Equation 2.108 and 2.109 yields
χblood − χplasma
Hct
= (1−Y) · (χdeoxy − χoxy) + χoxy − χplasma . (2.110)
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Assuming χplasma ≈ χwater [Schenck, 1996] and defining ∆χdo = χdeoxy− χoxy
and ∆χx = χx − χwater simplifies the equation to
∆χblood
Hct
= (1−Y) · ∆χdo + ∆χoxy . (2.111)
Equation 2.111 allows to quantify the venous oxygen saturation Yv from
the magnetic susceptibility of venous blood. ∆χdo has been estimated to be
2.26 ppm by Weisskoff and Kiihne [1992] but Spees et al. [2001] measured a
value of 3.39 ppm. Moreover, one has to keep in mind that the Hct in small
vessels can be lower by up to 15 % compared to larger vessels.
2.4.2 Oxygenation Parameters
The absolute consumption of oxygen in mol per tissue mass and time is given
by the metabolic rate of oxygen or by the cerebral metabolic rate of oxy-
gen (CMRO2) in case of brain tissue. Typical values in the healthy brain are
120-180µmol/100 g/min in grey matter and 40-80µmol/100 g/min in white
matter [Leenders et al., 1990; Ito et al., 2004]. The ratio of oxygen consump-
tion and delivery is defined as the oxygen extraction fraction (OEF) and can
also be considered as the relative change of oxygen saturation as the blood
travels through the capillary network from the arterial to the venous side
OEF =
[HbO2]a − [HbO2]v
[HbO2]a
= 1− Yv
Ya
. (2.112)
Owing to the autoregulation, the OEF should be uniform and homogeneous
throughout the healthy brain at rest and is usually around 40 % [Gusnard and
Raichle, 2001]. However, the OEF can become of interest in pathologies, such
as brain tumours, where both oxygen delivery and consumption can undergo
changes. CMRO2 and OEF are connected via the cerebral blood flow (CBF) with
CMRO2 ∝ OEF ·CBF . (2.113)
2.5 tumours of the brain and central nervous system
According to the World Cancer Report from 2014 [Stewart and Wild, 2014],
primary tumours of the brain and central nervous system (CNS) account for
only 2 % of all cancer types globally. Nonetheless, some types reveal a dispro-
portionally high mortality [Wen and Kesari, 2008]. One possible classification
of brain and CNS tumours is by the tissue of origin with examples shown
in Table 2.4. Another commonly used classification scheme is the grading
system of the World Health Organization (WHO) [Louis et al., 2007, 2016].
Grades range from I to IV, indicating the aggressiveness of each tumour type
and, thus, also treatment outcome. An overview of the different grades, cor-
responding characteristics and exemplary tumour types is given in Table 2.5.
Grades I and II are considered low-grade, whereas III and IV are considered
high-grade tumours.
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Table 2.4: Examples of different types of tumours of the brain and CNS with the corres-
ponding tissues of origin [American Association of Neurological Surgeons,
2019b].
Tissue of origin Tumour types
Astrocytes Astrocytoma
}
Glioma
Oligodendrocytes Oligodendroglioma
Ependyma Ependymoma
Neurons Medulloblastoma
Meningens Meningioma
Glioma make up approximately 80 % of all malignant primary brain tu-
mours [Ostrom et al., 2017] with the glioblastoma multiforme, a grade IV
astrocytoma, being the most frequent [Ostrom et al., 2017; Wen and Kesari,
2008]. Due to the high aggressiveness and extensive infiltration, patients with
glioblastoma multiforme have a median survival time of only 12 to 15 months
despite optimal treatment [Wen and Kesari, 2008]. In addition, glioblastoma
multiforme often reveal areas of extensive microvascular proliferation, espe-
cially in the periphery of the tumour [Wen and Kesari, 2008]. In spite of this
increased perfusion, the tumour often grows so rapidly that it eventually cuts
off its own blood supply, leading to necrosis in the tumour centre [Wen and
Kesari, 2008]. Moreover, the so-called Warburg effect can occur, which means
that the cancer cells start favouring metabolism by the less efficient anaerobic
glycolysis rather then the standard oxidative phosphorylation. This, however,
leads to a lower oxygen content inside the cells, i. e. hypoxia, and to an in-
creased production of metabolic waste. The reasons for the onset of the War-
burg effect in cancer are still debated among oncologist, especially since it
also occurs when enough oxygen is supplied to the cancer cells [Strickland
and Stoll, 2017].
In general, glioblastoma multiforme usually show a heterogeneously en-
hancing mass with a large peritumoural oedema in standard MRI. Strong en-
hancement in the periphery of the tumour is often seen in T1-weighted MRI
with a gadolinium (Gd) contrast agent indicating a disruption of the blood-
brain barrier. Unfortunately, treatment of high-grade glioma, especially of
glioblastoma multiforme, is still challenging due to the strong heterogeneity
of the tumour and infiltration of the surrounding tissue. Commonly, the tu-
mour is delineated with T1-weighted MRI + Gd and then surgically resected
as much as possible. Surgery is usually followed by radio- and/or chemo-
therapy to treat possible tumour residue that has infiltrated the surrounding
tissue [Wen and Kesari, 2008].
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Table 2.5: WHO grading of brain and CNS tumours including corresponding tissue
characteristics and tumour types [American Association of Neurological
Surgeons, 2019a].
WHO grade Characteristics Tumour types
Low
I
• Least malignant (benign)
• Possibly curable by sur-
gery alone
• Non-infiltrative
• Long-term survival
• Slow growing
• Pilocytic astrocy-
toma
II
• Relatively slow growing
• Somewhat infiltrative
• Might recur as higher
grade
• ‘Diffuse’ astrocy-
toma
High
III
• Malignant
• Infiltrative
• Tend to recur as higher
grade
• Anaplastic astro-
cytoma
• Anaplastic oligo-
dendroglioma
• Anaplastic
ependymoma
IV
• Most malignant
• Rapid growth, aggressive
• Widely infiltrative
• Rapid recurrence
• Necrosis prone
• Glioblastoma
multiforme
• Medulloblasto-
ma
3
M AT E R I A L S A N D M E T H O D S
This chapter covers all materials and methods used in this thesis from patient
and data acquisition to general image processing ending with the quanti-
fication of tissue oxygenation using quantitative susceptibility mapping and
quantitative blood oxygenation level-dependent techniques. Parts of this work
have been published in [Hubertus et al., 2019b] and [Hubertus et al., 2019c]
and the description of the corresponding methods is replicated here.
3.1 mr image acquisitions
3.1.1 Volunteers and Patients
MR images of seven healthy volunteers (three female, four male, age 27 ±
3 years) and one female patient with a histopathologic diagnosis of glioblasto-
ma multiforme (WHO grade IV) were acquired at the Medizinische Fakultät
Mannheim. The study had been approved by the local institutional ethics com-
mittee (Medizinische Ethikkommission II der Medizinischen Fakultät Mann-
heim) and has therefore been performed in accordance with the ethical stan-
dards laid down in the 1964 Declaration of Helsinki and its later amendments.
Written informed consent had been given prior to the measurements. In ad-
dition, clinical MRI data of five patients (one female, four male) with a his-
topathologic diagnosis of glioblastoma multiforme (WHO grade IV) and two
patients (one female aged 26, one male aged 38) with anaplastic astrocytoma
(WHO grade III) has been analysed retrospectively. This data had been ac-
quired at Weill Cornell Medical College in New York and the study had been
approved by the local institutional review board. The age averaged over all six
glioblastoma multiforme patients was 58± 15 years. The glioblastoma multi-
forme will from now on be referred to as glioblastoma and the anaplastic
astrocytoma as astrocytoma. Both tumour types are considered as high-grade
glioma.
3.1.2 Scanners
The healthy volunteers and one glioblastoma patient were scanned with a
clinical 3 T MAGNETOM Trio system using a 32-channel head coil (Siemens
Healthcare GmbH, Erlangen, Germany) at the Medizinische Fakultät Mann-
heim. A picture of the scanner and the coil is shown in Figure 3.1. Three of
the remaining tumour patients had been scanned with a clinical 1.5 T and
the other four with a 3 T scanner (Siemens Healthcare GmbH, Erlangen, Ger-
many; GE Healthcare, Chicago, USA) at Weill Cornell Medical College.
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Figure 3.1: 3 T MAGNETOM Trio system with 32-channel head coil from Siemens
Healthcare GmbH (Erlangen, Germany), which was used for volunteer
measurements.
3.1.3 Sequences
multi-gradient echo Knowledge of the MR phase evolution with time
is necessary for QSM analysis. Hence, the FID of the MR signal has to be
sampled with multiple gradient echoes. For this purpose, a 3D multi-gradient
echo (GRE) sequence was acquired. The sequence parameters for the volun-
teer measurements were: TR = 61 ms; TE1 = 4.5 ms; ∆TE = 5.5 ms; 8 echoes;
matrix size = 256 x 192 x 72; voxel size = 0.9 x 0.9 x 1.4 mm3; flip angle =
15◦; GRAPPA factor = 2 [Griswold et al., 2002]; unipolar readout; acquisition
time = 7:51 min. The raw complex MRI data was saved.
The sequence parameters for the clinical patient measurements varied in
the range: TR = 49 − 69 ms; TE1 = 4.5 − 11 ms; ∆TE = 4.1 − 10.3 ms; 6 −
11 echoes; matrix size = 256− 512 x 192− 512 x 16− 34; voxel size = 0.5−
0.9 x 0.5− 0.9 x 1.4− 3 mm3; flip angle = 15− 20◦. The magnitude and phase
images were saved.
pseudocontinuous arterial spin labelling Unbalanced axial 2D
pseudocontinuous arterial spin labelling (pCASL) data with an EPI readout
was acquired in all healthy volunteers and one glioblastoma patient to de-
termine CBF. The sequence parameters were: TR = 5000 ms; TE = 16 ms;
labelling duration (LD) = 1500 ms; post-labelling delay (PLD) = 1500 ms; mat-
rix size = 80 x 80; 28 slices; voxel size = 3 x 3 x 3 mm3; distance factor = 20%;
flip angle = 90◦; GRAPPA factor = 2 [Griswold et al., 2002]; phase partial
Fourier = 7/8 [Feinberg et al., 1986]; 20 averages; acquisition time = 3:45 min.
As suggested by Alsop et al. [2015], the labelling plane was placed perpen-
dicular to the arteries in the neck and roughly 80 mm inferior of the line
connecting the anterior and posterior commissure.
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dynamic contrast enhanced mri Seven of the high-grade glioma pa-
tients had received a T1-weighted 3D dynamic contrast enhanced (DCE) acqui-
sition with contrast agent injection (1 ml/10 kg body weight of Gadobutrol) in
order to estimate perfusion parameters. The parameters varied in the range:
TR = 3.5− 5.8 ms; TE1 = 1.2− 1.3 ms; temporal resolution = 5.6− 10.2 ms;
24− 40 time points; matrix size = 256 x 256 x 48− 72; voxel size = 0.9 x 0.9 x 5
mm3; flip angle = 13− 25◦.
gradient echo sampling of spin echo The gradient echo sampling
of spin echo (GESSE) sequence was proposed by Yablonskiy and Haacke [1997]
in order to generate both T2- and T∗2 -weighted images by sampling a spin
echo with several additional gradient echoes both during re- and subsequent
dephasing. All seven healthy volunteers were scanned with an axial 2D GESSE
sequence for qBOLD analysis with the following parameters: TR = 2780 ms;
TE1 = 29 ms; ∆TE = 2 ms; 32 echoes; spin echo (SE) at 10th echo; matrix
size = 128 x 96; 25 slices; voxel size = 2 x 2 x 2 mm3; distance factor = 33%;
flip angle = 90◦; phase partial Fourier = 7/8 [Feinberg et al., 1986]; unipolar
readout; 3 averages; acquisition time = 10:00 min.
magnetisation-prepared rapid gradient echo 3D magnetisation-
prepared rapid gradient echo (MPRAGE) [Mugler III and Brookeman, 1990]
data was acquired in all seven healthy volunteers and one glioblastoma pa-
tient to have a T1-weighted morphological reference. The parameters were:
TR = 1900 ms; TE = 2.4 ms; inversion time = 900 ms; matrix size = 256 x 256 x
176; voxel size = 1 x 1 x 1 mm3; flip angle = 9◦; GRAPPA factor = 2 [Griswold
et al., 2002]; acquisition time = 4:18 min.
Available T1- or T2-weighted images were used as anatomical reference for
the remaining seven high-grade glioma patients.
3.2 image registration and segmentation
Image registration among sequences was performed with the statistical para-
metric mapping software SPM12 (Wellcome Trust Centre for Neuroimaging,
London, UK) using the default values. SPM12 was also utilised to segment
the MPRAGE data into binary grey matter (GM), white matter (WM) and cere-
brospinal fluid (CSF) masks applying a probability threshold of 0.5. All post-
processing was done with MATLAB R2017a (MathWorks, Natick, MA, USA).
3.3 perfusion estimation
3.3.1 pCASL
Both the control (Mc) and tag (Mt) images from the pCASL sequence were
averaged and together with the PD-weighted image (MPD) were used to calcu-
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late the CBF in ml/100 g brain tissue/min according to the recommendations
from Alsop et al. [2015] as
CBF =
6000 · λ · (Mc −Mt) · exp(PLD/T1,blood)
2α · T1,blood ·MPD · (1− exp(−LD/T1,blood)) . (3.1)
Here, λ = 0.9 ml/g is the blood-brain partition coefficient [Herscovitch and
Raichle, 1985], T1,blood = 1650 ms is the longitudinal relaxation time of arterial
blood at 3 T [Lu et al., 2004] and α = 0.86 is the labelling efficiency [Aslan
et al., 2011]. The cerebral blood volume (CBV) in % was estimated from the CBF
in ml/100 g brain tissue/min according to the empirical relationship found by
linear regression of the combined grey and white matter data from Leenders
et al. [1990]
CBV = 0.0723 ·CBF+ 1.144 . (3.2)
3.3.2 DCE
In order to estimate the CBF and CBV, a two-compartment exchange model
was fitted to the DCE data using the ROCKETSHIP framework [Barnes et al.,
2015]. The exchange model is the most general two-compartment model as-
suming a plasma compartment with a plasma flow fp in ml/100 g brain
tissue/min and a plasma volume vp in % relative to the total volume. The
second compartment is the interstitial fluid that occupies the extracellular
volume ve also in %. The permeability-surface area product PS is the ex-
change rate between the two compartments and is considered the same in
both directions. A schematic overview of the model is illustrated in Figure 3.2.
Without decay of the contrast agent, the differential equations governing the
tracer-kinetics can be written as
ve
dce
dt
(t) = PS · (cp(t)− ce(t))
vp
dcp
dt
(t) = PS · (ce(t)− cp(t)) + fp · (ca(t)− cp(t)) .
(3.3)
These yield a residue function R(t) in Equation 2.90 that has a bi-exponential
form in the parameters fp, vp, ve and PS [Ingrisch and Sourbron, 2013; Barnes
et al., 2015]. To quantify concentration curves, the temporal DCE signal was
corrected for T1 decay assuming T1,blood = 1664 ms for a large vessel haemato-
crit Hct = 0.42 [Lu et al., 2004] and a relaxivity r1 = 4.6 s−1mM−1 at 1.5 T
and r1 = 4.5 s−1mM−1 at 3 T for Gadobutrol [Shen et al., 2015]. A ROI was
manually placed inside the superior sagittal sinus as proposed by Keil et al.
[2017] and a bi-exponential fit to the averaged signal within was conducted in
order to establish the AIF ca(t). Temporal smoothing with a moving average
filter was applied to the data before the final deconvolution. CBF in ml/100 g
brain tissue/min and CBV in % were calculated according to
CBF = fp/(1−Hct) (3.4)
CBV = vp/(1−Hct) (3.5)
again with the large vessel haematocrit Hct = 0.42 [Lu et al., 2004].
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Figure 3.2: Schematic illustration of the two-compartment exchange model with a
plasma (p) and extracellular (e) compartment. Parameters of the model
are the plasma flow fp, plasma volume vp, extracellular volume ve and
permeability-surface area product PS. The exchange rate PS is assumed
to be the same in both directions.
3.4 quantitative susceptibility mapping
Quantitative susceptibility mapping (QSM) is an image processing technique
that aims at quantifying the magnetic susceptibility χ from its effect on MRI
phase data [De Rochefort et al., 2008; Liu et al., 2009; Kressler et al., 2010;
Wang and Liu, 2015; Schweser et al., 2016].
Equation 2.105 has to be inverted in order to determine χ from the magnetic
field. This deconvolution problem is called the field to source inversion. Con-
volutions are most effectively executed in Fourier space owing to the Fourier
convolution theorem. Thus, by defining the relative difference field (RDF) as
RDF(~r) =
B(~r)− Bext(~r)
Bext(~r)
(3.6)
one obtains the handy equation
F (RDF)(~r) = F (χ)(~r) · F (b˘χ)(~r) . (3.7)
Solving Equation 3.7 for χ is one of the main tasks in QSM. This is not straight-
forward as the problem is ill-posed or more specifically underdetermined due
to the unit dipole function b˘χ(~r). Its Fourier transform is defined as
b˘χ(~k) = F (b˘χ)(~r) = 13 −
k2z
||~k||22
=
1
3
− cos2 θ (3.8)
with the azimuthal angle θ and, therefore, zero on a conical surface at the so-
called magic angle θm = 54.74◦ (see Figure 3.3). This makes a simple inversion
impossible. A detailed overview over all approaches to tackle these two and
other general issues in QSM is given in Wang and Liu [2015] and Schweser
et al. [2016].
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Figure 3.3: Central slice through the field pattern of a unit-dipole function given by
Equation 2.99 (left) and through its Fourier transform (FT) given by Equa-
tion 3.8 (right). The amplitude is given in a.u.. The Fourier transform of
the dipole is zero on a cone surface with opening angle θm = 54.74◦. B0
indicates the direction of the magnetic field.
The RDF in Equation 3.6 is defined with the magnetic field itself; however,
in MRI one usually measures the relative Larmor frequency ∆ fMR(~r). It can be
approximated as
∆ fMR(~r) ≈ − γ2pi [Bb(~r) + B0 · (χ(~r) ∗ b˘χ(~r))] (3.9)
with the macroscopic unit dipole function b˘χ(~r) as defined in Equation 2.101
and the static inhomogeneous or so-called background field Bb(~r) that com-
bines all hardware-related field offsets. A more detailed derivation with all
assumptions made, such as neglecting the chemical shift, can be found in
Schweser et al. [2016]. Assuming a constant susceptibility within one voxel,
the frequency offset in this voxel can also be expressed as signal phase de-
pending on the echo time TE according to
ϕ(TE) = ϕ0 + 2pi · ∆ fMR · TE = ϕ0 + ∆ϕ(TE) (3.10)
with the time-independent phase ϕ0 at t = 0 owing to transmit and receive
processes. This means, by evaluating the MR signal phase, the frequency off-
sets and, thus, the RDF can be determined by combining Equation 3.9 and
3.10. Yet, another main task in QSM is to accurately disentangle the frequency
offsets induced by the static inhomogeneities (Bb(~r)) and by the magnetic
susceptibility (χ(~r)). This is a crucial step as any remaining contribution of
Bb(~r) to the RDF will introduce biases into the final χ maps.The toolbox can
be downloaded
from
http://pre.
weill.cornell.
edu/mri/pages/
qsm.html
The QSM analysis comprises a full processing pipeline to get from the initial
phase and magnitude GRE images to the final map of the magnetic suscepti-
bility χ (see Figure 3.4) and each step is described in this section. Most of the
image processing for QSM implemented for this work is based on the MEDI
toolbox, which is openly available from Cornell MRI Research Lab at Weill
Cornell Medical College.
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Figure 3.4: Schematic visualisation of the QSM processing pipeline from phase and
magnitude images to the final χ map. The background field removal re-
quires a mask of the brain parenchyma.
3.4.1 MR Image Reconstruction
Due to a phase reconstruction issue of the VB19 software installed on the
MAGNETOM Trio system (Siemens Healthcare GmbH, Erlangen, Germany)
at the Medizinische Fakultät Mannheim, the raw complex MRI data of the
GRE sequence was reconstructed manually off-line. This was done according
to Robinson et al. [2017]. The magnitude images from all 32 channels at the
nth TE were combined to one magnitude image Mn by sum-of-squares
Mn =
√√√√ 32∑
j=1
M2n,j . (3.11)
The phase image at TE1 was subtracted from all subsequent phase images for
each channel separately in order to remove channel-dependent phase offsets.
Afterwards, the phase images at the nth TE were combined to one phase
image ϕn by exponential addition weighted with the magnitude images
ϕn = 6
[
32
∑
j=1
M2n,j · e−i(ϕn,j−ϕ1,j)
]
. (3.12)
The magnitude and phase images of the GRE sequences acquired at Weill
Cornell Medical College were correctly reconstructed by the scanner and were
used directly without further processing.
3.4.2 Brain Mask Generation
A binary mask of the brain parenchyma was generated in order to exclude
the background and skull from subsequent postprocessing. First, a threshold
was applied to the magnitude image averaged over all echoes. Second, the
biggest connected component of this initial mask was then refined by the
morphological operations opening and closing. Finally, the resulting mask
was eroded with a spherical kernel of radius r = 5 mm.
The masks for the brain tumour patients acquired at Weill Cornell Medical
College were created with the brain extraction tool [Smith, 2002] from the
FMRIB software library followed by an erosion with a spherical kernel of
radius r = 3 mm.
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3.4.3 Frequency Offset Estimation
The frequency offset ∆ f represented as phase increment per echo ∆ϕ = 2pi ·
∆ f ·∆TE was estimated by fitting the model
Sc(n) = Mn · ei(∆ϕ·(n−1)+ϕ0) (3.13)
to the complex MRI data by a weighted least-squares optimisation. n is the
echo number and Mn is the magnitude image at the nth echo so that only ∆ϕ
and ϕ0 remain as fitting parameters. The complex data rather than merely
the phase data was utilised for fitting owing to the beneficial Gaussian noise
distribution of the former [De Rochefort et al., 2008; Kressler et al., 2010; Liu
et al., 2013].
3.4.4 Spatial Phase Unwrapping
The phase increments reconstructed in Subsection 3.4.3 are only defined in
the range of [−pi,pi] so that spatial unwrapping of the phase maps is required.
This was either done by Laplacian operations [Schofield and Zhu, 2003] or by
a region growing algorithm [Cusack and Papadakis, 2002]. The latter starts
unwrapping areas with high SNR where the data can be considered reliable
and continues into areas with lower and lower SNR. Which algorithm worked
best strongly depended on the input data and hence was determined indi-
vidually.
3.4.5 Background Field Removal
In order to correctly estimate the tissue magnetic susceptibility, the phase
contribution from non-tissue sources, the so-called background field, had to
be removed from ∆ϕ. Here, two different algorithms were utilised for back-
ground field removal. Both either directly or indirectly exploit the fact that
the z-component of the background field ~Bb is harmonic, i. e. solves Laplace’s
equation ∇2Bb = 0, whereas the z-component of the local field originating
from inside the brain ~Bloc is non-harmonic, i. e. ∇2Bloc 6= 0. The mask of the
brain parenchyma generated in Subsection 3.4.2 was used as ROI from which
the local field is assumed to be generated. Everything outside the brain mask
was considered background.
projection onto dipole fields (pdf) This algorithm assumes that
any unit dipole field originating within the ROI is orthogonal to all possible
unit dipole fields originating in the background. Hence, the contribution of
the background field to the total measured field can be extracted by taking
the inner product, i. e. projecting the total field onto a combination of all
possible unit dipole fields from the background. The local brain field can
then be reconstructed by subtracting the projection from the total measured
field. This approach has been proposed and validated by Liu et al. [2011] and
was applied to the healthy volunteer data.
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laplacian boundary value (lbv) This algorithm solves ∇2Bb = 0
with boundary conditions directly using a finite difference scheme. As the
magnitude of Bb is usually at least one order of magnitude larger than of
Bloc, the background field is approximated as the total measured field at the
brain boundary [Zhou et al., 2014]. This approach was applied to the tumour
patient data.
After removal of the background field, the signal contribution of the RDF
was defined as
SRDF = eiRDF = ei∆ϕloc/(ω0∆TE) (3.14)
with the Larmor frequency ω0.
3.4.6 Field to Source Inversion
The last step in the QSM pipeline is solving the ill-posed field to source inver-
sion. In this work, the morphology enabled dipole inversion (MEDI) algorithm
[Liu et al., 2012, 2013] was applied for this purpose. MEDI tackles the under-
determined problem by adding an L1 regularisation term to the least-squares
minimisation that promotes solutions of χ that have consistent edges with
the corresponding magnitude image. Specifically, it solves the minimisation
problem
χ∗ = argminχ
∥∥mg ◦ (gχ)∥∥1 + λ1 ‖W ◦ (exp (iD ∗ χ)− SRDF)‖22 . (3.15)
Here, χ is the 3D matrix of the magnetic susceptibility, SRDF is the 3D matrix Boldfaced
variables refer to
3D matrices.
of the signal contribution of the relative difference field from Equation 3.14,
W ∝ 1/σ2 is a 3D weighting matrix with σ being the error estimation of
∆ϕ from the fit in Equation 3.13 and g = ∂/∂x + ∂/∂y + ∂/∂z is a gradient
operator. The norms can be considered generalised vector norms defined as
‖A‖p =
(
q
∑
i=1
r
∑
j=1
s
∑
k=1
|ai,j,k|
)1/p
(3.16)
for a matrix A of size q x r x s and ∗ is the convolution operator and ◦ is the
Hadamard product.
mg =
0 , ||g M|| ≥ µ1 , ||g M|| < µ (3.17)
is a 3D binary matrix, which excludes edges from the GRE magnitude M data
using a threshold µ that depends on the image noise. λ1 is a scalar weight-
ing factor that was set to 1000. Equation 3.15 was solved with a conjugate
gradient method in an iterative fashion by tayloring the cost-function to the
first order and calculating its gradient in every step. The added L1 regular-
isation in Equation 3.15 sparsifies the solution with regard to edges in the
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final χ that are not present in the original magnitude M. As b˘χ(~0) in Equa-
tion 3.8 is not well defined, the susceptibility maps from QSM have always
to be referenced to a certain tissue. We chose CSF here as a water surrogate
since the fundamental equation (2.111) that links blood oxygen saturation and
blood magnetic susceptibility requires the susceptibility to be referenced to
water. The magnetic susceptibility of CSF was manually averaged across the
CSF mask generated in Subsection 3.4.1 and subtracted from the reconstructed
map for the healthy volunteers.
The field to source inversion for the glioma patients was done with MEDI
with automatic CSF zero reference (MEDI+0) [Liu et al., 2018]. MEDI+0 further
penalises solutions with heterogeneous magnetic susceptibilities inside the
CSF by adding the L2 regularisation term
regL2 = λ2
∥∥∥mCSF ◦ (χ− (mCSF ◦ χ))∥∥∥2
2
(3.18)
to Equation 3.15. Here, mCSF is a 3D binary matrix of the ventricles, which is
automatically generated by fitting R∗2 to the magnitude data M, applying a
threshold to the resulting maps and by exploiting connectivity in the central
brain region [Liu et al., 2018]. (mCSF ◦ χ) is the mean value of the magnetic
susceptibility within mCSF and is subtracted from the final χ map. Voxels
inside the tumour masks were excluded from mCSF. The weighting factor λ2
was set to 100.
3.5 quantitative blood oxygenation level-dependent approach
3.5.1 Tissue Model
In 1994, Yablonskiy and Haacke [1994] developed a tissue model that de-
scribes the MR signal behaviour in the presence of static magnetic field in-
homogeneities created by the blood vessel network. They called it quanti-
tative blood oxygenation level-dependent (qBOLD) model and assumed one
compartment each for tissue and blood vessels with a different magnetic sus-
ceptibility. Approximating the blood vessel network as infinitely long and
randomly oriented cylinders, they found
S(t) = S0 · exp (−ν · f (δω · t)− R2 · t) (3.19)
for the signal decay in a gradient echo experiment. The characteristic fre-
quency shift due to the presence of the blood vessel network is given by
δω =
1
3
· γ · B0 · [Hct ·∆χ0 · (1−Y)] (3.20)
with the susceptibility difference between fully de- and oxygenated red blood
cells ∆χ0 in SI units. f (δω · t) can be represented as a generalised hypergeo-
metric function [Sukstanskii and Yablonskiy, 2001]
f (δω · t) = 11F2
({
−1
2
}
;
{
3
4
,
5
4
}
;− 9
16
(δω · t)2
)
− 1 . (3.21)
3.5 quantitative blood oxygenation level-dependent approach 53
This leaves the initial signal S0, the transverse relaxation rate R2, the deoxy-
genated blood volume ν and the venous oxygen saturation Y as parameters
of the model. Equation 3.19 can be separated in two distinct regimes, the
so-called short and long term regime, in which the signal decay can be ap-
proximated as
S(t) = S0 · exp
(
−0.3 · ν · (δω · t)2 − R2 · t
)
, |δω · t| < 1.5 (3.22)
S(t) = S0 · exp (−ν · (δω · t− 1)− R2 · t) , |δω · t| ≥ 1.5 (3.23)
respectively. This means that the logarithmic signal decays linearly with t
and δω in the long term regime; yet it decays quadratically with t and δω in
the short term regime. Hence, a proper separation of the qBOLD parameters
requires the sampling of both domains. When sampling the FID with standard
gradient echo sequences however, the short term regime is restricted to the
first few echoes. It is therefore that Yablonskiy and Haacke [1997] proposed
the gradient echo sampling of spin echo (GESSE) sequence in order to sample
the short term regime both before and after the spin echo (SE). In this case,
Equation 3.19 becomes
S(t) = SSE · exp (−ν · f (δω · τ)− R2 · τ) (3.24)
with τ = t − tSE being referenced to the time of the spin echo tSE and the
signal magnitude at the spin echo SSE.
The qBOLD model assumes that the system is in the so-called static dephas-
ing regime, i. e. the characteristic time for a proton to diffuse a distance equal
to the radius of the vessels is longer than tc = 1/δω. This approximation is
generally accepted in high-field MRI. In addition, Equation 3.20 assumes that
there is no frequency shift between the tissue compartment and fully oxy-
genated blood inside the vessel network. In general, the qBOLD model aims
at disentangling the effects of the microscopic (much smaller than the voxel
size) field inhomogeneities described by R2 from mesoscopic (in the order of
the voxel size) field inhomogeneities, which are mainly caused by the differ-
ent susceptibility of the blood vessels. However, there are also macroscopic
(much larger than the voxel size) field inhomogeneities, for example from
non-uniform B0 and B1 fields, which have to be removed before the model
can be applied.
3.5.2 Correction for Macroscopic Field Inhomogeneities
The magnitude signal S(t) of the GRE and GESSE sequence was corrected for
macroscopic inhomogeneities [Dickson et al., 2010; Hernando et al., 2012] us-
ing the frequency offset of the background field ωb = γ · Bb created during
the background field removal step (Subsection 3.4.5) of the QSM reconstruc-
tion. For this, the scaling
S(t)→ S(t)
Sb(t)
· Sb (0) (3.25)
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was applied with
Sb (t) =
3
∏
j=1
∫ ∞
−∞
exp
(−i · k j · xj) · SRFj(xj − xj,0)dxj (3.26)
and
k j =
d
dxj
ωb · t ·∆xj . (3.27)
Here, the macroscopic background field was approximated to the first or-
der and the image voxel size ∆x = (∆x1,∆x2,∆x3) and the spatial response
function (SRF) for a voxel centred around xj,0 was used. The SRF differs for fre-
quency/phase encoding and slice selection [Hernando et al., 2012] leading to
a distinct correction for the 3D GRE and 2D GESSE. The SRF for frequency/phase
encoding can be represented by a normalised sinc function restricted to its
central lobe by a boxcar function R(x) of width 1 centred around 0 [Dickson
et al., 2010]
SRF (x) = sin(pix)/(pix) · R(x) . (3.28)
Combining Equation 3.26 and 3.28 and exploiting the Fourier convolution
theorem yields
Sb,GRE (t) =
3
∏
j=1
∫ k j+pi
k j−pi
sinc
(
k
2
)
dk (3.29)
for correction of the GRE magnitude. The correction is the same in all three
dimensions as the sequence utilises only frequency/phase encoding. For 2D
acquisitions however, the SRF in the direction of slice selection is given by a
mere boxcar function with the slice thickness as width [Hernando et al., 2012].
This simplifies the integral in Equation 3.26 for the third dimension yielding
Sb,GESSE (t) = sinc
(
k3
2
)
·
2
∏
j=1
∫ k j+pi
k j−pi
sinc
(
k
2
)
dk (3.30)
for the overall correction of the GESSE magnitude.
3.6 tissue oxygenation : qsm+qbold
In order to assess the brain tissue oxygenation of the seven healthy volun-
teers, a combined QSM and qBOLD analysis (QSM+qBOLD) based on Cho et al.
[2018] was carried out for the GESSE and GRE data and the results from both ac-
quisitions were compared. This study has been published as [Hubertus et al.,
2019b] and the description of the methods presented in this section follows
named publication.
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3.6.1 GESSE Analysis
OEF in % and CMRO2 in µmol/100 g/min were reconstructed as
OEF = 1− Y
Ya
(3.31)
CMRO2 = CBF ·OEF · [H]a . (3.32)
Assuming an arterial oxygenation of Ya = 0.98 and a haematocrit of Hct =
0.357 [Sakai et al., 1985] gives an oxygenated haeme molar concentration in ar-
terioles of [H]a = 7.377µmol/ml [Cho et al., 2018], leaving the venous oxygen-
ation Y as an unknown. Additional unknowns were the deoxygenated blood
volume ν, the transverse relaxation rate R2, the signal at the spin echo of
the GESSE S0 and the non-blood susceptibility χnb. The latter was introduced
to account for possible frequency shifts between fully oxygenated blood and
tissue caused by iron deposition for instance. QSM and qBOLD data were com-
bined into one minimisation term culminating in the cost function [Cho et al.,
2018]
Y∗, ν∗, R2∗, S0∗,χnb∗ = argminY,ν,R2,S0,χnb
{
∑
TE
∥∥SGESSE (TE)− FqBOLD (Y, ν, R2, S0,χnb, TE)∥∥22
+w · ‖χ− FQSM (Y, ν,χnb)‖22
}
= argminY,ν,R2,S0,χnb
{
EqBOLD + w · EQSM
}
.
(3.33)
The QSM function FQSM was defined as
FQSM (Y, ν,χnb) =
[
χba
α
+ ψHb ·∆χHb ·
(
1− (1− α) ·Ya
α
−Y
)]
· ν
+
(
1− ν
α
)
· χnb
(3.34)
with the fully oxygenated blood susceptibility in SI units χba = −0.1082 ppm
[Zhang et al., 2017], the deoxygenated fraction of the total blood volume α
set to 0.77 [An and Lin, 2002b], the haemoglobin volume fraction ψHb =
0.0909 [Zhang et al., 2015; Savicki et al., 1984] and the susceptibility difference
between de- and oxyhaemoglobin ∆χHb = 12.522 ppm [Cho et al., 2018] also
in SI units.
The qBOLD function FqBOLD was adapted to describe the GESSE signal behav-
iour [Yablonskiy and Haacke, 1994; Yablonskiy, 1998] according to
FqBOLD (Y, ν, R2, S0,χnb, t) = S0 · exp (−ν · f (δω · τ)− R2 · τ) (3.35)
with τ = t − tSE being referenced to the time of the spin echo SE and the
generalised hypergeometric function f (δω · τ) as defined in Equation 3.21.
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δω is the frequency shift [Cho et al., 2018] due the presence of deoxygenated
blood inside the tissue and given by
δω (Y,χnb) =
1
3
· γ · B0 · [Hct ·∆χ0 · (1−Y) + χba − χnb] (3.36)
with the susceptibility difference between fully de- and oxygenated red blood
cells in SI units ∆χ0 = 3.481 ppm [Jain et al., 2012]. Equation 3.21 was approx-
imated by a Taylor expansion up to the 60th order to reduce the computa-
tional cost of the optimisation.
Since the qBOLD function in Equation 3.33 is highly sensitive to SNR and
initial parameter values, the starting values were estimated on a low resolu-
tion data set, i. e. with a reduction of the in-plane resolution by a factor of
4. The starting values for this initial minimisation were Y = 60 %, ν = 3 %,
R2 = 12 Hz, S0 = SGESSE(tSE) and χnb = χba. These maps of initial values
were scaled up to the original data size and the fitting parameters were nor-
malised as xnorm → x/x with the mean x of the starting value maps in order
to have a similar weighting for all five unknowns. Equation 3.33 was solved
using a MATLAB R2017a (MathWorks, Natick, MA, USA) implementation of
the limited-memory projected quasi-Newton (L-BFGS) algorithm [Schmidt,
2008; Schmidt et al., 2009] with both energy terms EqBOLD and EQSM being
normalised to their starting value. The optimisation was stopped when the
relative change of the minimisation function was less than 0.005 for a total of
100 iterations. When no physiological (0 ≤ {Y, ν} ≤ 1) or logical (0 ≤ R2, S0)
constraints were available, |xnorm| < 4 was enforced. The weighting factor
w ∈ {10−2, 10−1, . . . , 106} was determined with an L-curve approach [Hansen
and O’Leary, 1993].
3.6.2 GRE Analysis
The main difference to the GESSE analysis is the qBOLD function [Ulrich and
Yablonskiy, 2016]
FqBOLD (Y, ν, R2, S0,χnb, t) = S0 · exp (−R2 · t) ·
(
1− ν
1− ν · f (δω · t)
+
1
1− ν · f (ν · δω · t)
) (3.37)
and the initial parameter guess. Equation 3.37 is merely an approximated
solution of the qBOLD model, which, however, has been considered beneficial
for parameter separation in GRE data when using least-squares optimisations
[Ulrich and Yablonskiy, 2016]. The starting value for Y was estimated from
the straight sinus assuming a haematocrit ratio of 0.759 between large vessels
and brain tissue, a large vessel ψHb = 0.1197, χnb = 0 and ν = 100 %. The
straight sinus was manually segmented by a neuroradiologist with 7 years of
experience. Approximating the deoxygenated with the total CBV, the initial
values for ν in % (ml blood/100 ml brain) were estimated from the CBF maps
in ml/100 g/min according to Equation 3.2 and assuming a brain density of
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1 g/ml. The initial value of χnb was set to χba. Accounting for Y, ν and χnb in
Equation 3.37, the starting values for S0 and R2 were determined by fitting a
single exponential function to the remaining signal decay. Equation 3.33 was
directly solved for the high resolution data without intermediate steps.
3.6.3 Statistics
Mean values and standard deviations of OEF, ν, R2, χnb, CBF and CMRO2 for
every subject were averaged across combined grey and white matter (GM+WM)
as well as for grey matter (GM) and white matter (WM) separately. The five
most inferior slices from the GESSE acquisition were not taken into account
as most of them revealed obvious artefacts for OEF and ν. The means from
all subjects were combined to an intersubject mean with standard deviation.
Student’s t-test was performed to determine significant differences (p < 0.05)
between the means from the GESSE and GRE data. The same comparison was
carried out for the means from GM and WM within each acquisition type.
3.6.4 Conditioning
The relative condition number (rCN) of Equation 3.35 and 3.37 with respect to
Y and ν was determined according to
rCN =
|JY,ν|m∥∥FqBOLD(Y, ν)∥∥2/‖(Y, ν)‖2 (3.38)
with the matrix norm |J|m = max
||x||=1
||Jx|| and the Jacobian matrix
JY,ν =

∂FqBOLD(Y,ν,TE1)
∂Y
∂FqBOLD(Y,ν,TE1)
∂ν
...
...
∂FqBOLD(Y,ν,TEend)
∂Y
∂FqBOLD(Y,ν,TEend)
∂ν
 . (3.39)
Y and ν were varied in the range Y = 30, 35, ..., 70 %, ν = 1, 1.5, ..., 5 % and
the other parameters were fixed to R2 = 11.5 Hz, χnb = χba + 100 ppb and
S0 = 1000 a.u. with TE taken from the two clinical sequences respectively.
3.6.5 Simulation
A full brain single- and multi-compartment simulation was based on the
Zubal head phantom [Zubal et al., 1994]. A 256 x 256 x 128 data set of GESSE
and GRE signal as well as the corresponding magnetic susceptibility was mod-
elled according to Equation 3.35, 3.37 and 3.34 respectively. The ground truth
parameters were Y = 60 %, ν = 4 %, R2 = 11.5 Hz, χnb = −40 ppb, S0 =
1000 a.u. for grey matter, Y = 60 %, ν = 2 %, R2 = 13.0 Hz, χnb = −50 ppb,
S0 = 800 a.u. for white matter and TE as above. Gaussian noise was added
to the data sets to have an SNR = 100 at the GESSE spin echo and first GRE
echo, which is in accordance with the clinical acquisitions. The ground truth
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OEF value and ν distribution were used for initialisation of the GRE fit and
the reconstruction was carried out with the same approach as for the clinical
GRE data. The simulated GESSE data was reconstructed twice: first, initialised
with the ground truth OEF and the mean value of the ground truth ν distri-
bution using the same approach as for the clinical GESSE data; and second,
initialised with the ground truth OEF and ν distribution using the same ap-
proach as for the clinical GRE data. In all three cases, the reconstructed val-
ues were compared to the ground truth using the mean root squared error
MRSE = ((x− xtrue)/xtrue)2 over the full data set to determine accuracy.
The multi-compartment simulation modelled three compartments in white
matter: a CSF compartment with R2,CSF = 4 Hz, a tissue compartment with
R2,t = 13 Hz and a myelin compartment with R2,m = 67 Hz. The correspond-
ing weights were wCSF = 5 %, wt = 84 % and wm = 11 %. Grey matter was
simulated with only two compartments R2,CSF = 4 Hz and R2,t = 11.5 Hz and
weights wCSF = 5 %, wt = 95 % [Whittall et al., 1997; Yablonskiy et al., 2013].
An additional frequency offset ∆ fCSF = 5 Hz with no initial phase difference
was assumed for the CSF compartment in both cases [He and Yablonskiy,
2007]. R2,t was considered as ground truth regarding the accuracy of R2.
3.7 tissue oxygenation : artificial neural networks
An ANN was trained for combined QSM+qBOLD analysis of the GRE data from
all seven healthy volunteers and compared to the results of the conventional
least-squares approach in Subsection 3.6.2 that used quasi-Newton (QN) op-
timisation. This study has been published as [Hubertus et al., 2019c] and the
description of the methods presented in this section follows named publica-
tion.
3.7.1 Network Architecture and Model
The feed-forward network was implemented using the Neural Network Tool-
box from MATLAB R2017a (MathWorks, Natick, MA, USA) similarly to Dom-
sch et al. [2018]. It consisted of one input layer, one hidden layer with 10 nodes
and one output layer. A schematic diagram of an arbitrary feed-forward net-
work is illustrated in Figure 3.5.
The network emulated the exact solution of the qBOLD model for the FID
[Yablonskiy and Haacke, 1994; Yablonskiy, 1998]
SANN (Y, ν, R2, S0,χnb, t) = S0 · exp (−ν · f (δω · t)− R2 · t) (3.40)
with the generalised hypergeometric function f (Equation 3.21) and the fre-
quency shift δω (Equation 3.36). The remaining constants are the same as in
Subsection 3.6.1. Similarly, the magnetic susceptibility χANN (Y, ν,χnb) was
modelled according to Equation 3.34.
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Figure 3.5: Schematic diagram of a feed-forward neural network with one input, hid-
den and output layer. The number of inputs, hidden nodes and outputs
are chosen arbitrarily.
3.7.2 Network Training
107 parameter sets of Y, ν, R2, χnb and S0 were randomly generated with each
parameter having a Gaussian distribution. Half of the sets physiologically rep-
resented grey matter with mean ± standard deviation being Y = 60± 30 %,
ν = 4 ± 2 %, R2 = 12 ± 6 Hz and χnb = −40 ± 40 ppb; the other half rep-
resented white matter with Y = 60 ± 30 %, ν = 4 ± 2 %, R2 = 17 ± 4 Hz
and χnb = −50 ± 40 ppb. These values were estimated from the results of
Subsection 3.6.2. S0 was calculated from Equation 3.40 so that S (TE1) = 1.
The GRE signal decay was modelled for these parameter sets according to
Equation 3.40 using the echo times t = TE from the in vivo sequence of the
healthy volunteers (Subsection 3.1.3). Gaussian noise was added to the real
and complex signal to obtain an SNR = 100 at the first echo, which corres-
ponded to the in vivo data. The magnitude signal was then normalised to the
first echo. Magnetic susceptibilities were estimated from Equation 3.34. 80 %
of the parameter sets were used for training whereas 10 % each were utilised
for validation and testing. The weights of the network were adjusted during
training by minimising the sum-of-squares error between the parameter pre-
diction and ground truth using a Levenberg-Marquardt optimisation. Train-
ing and reconstruction were carried out on a personal computer with an Intel
Core i5− 6500 3.20 GHz processor (Intel, Santa Clara, California, USA) and
stopped when 100 iterations were reached.
3.7.3 Network Input and Output
After training, the artificial neural network took both the normalised GRE
magnitude signal and the magnetic susceptibility from QSM as an input
input =

S(TE1)/S(TE1)
...
S(TE8)/S(TE1)
χ
 (3.41)
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and returned
output = (Y, R2, ν,χnb, S0/S(TE1))
T . (3.42)
This was done for every voxel and final OEF maps were calculated according
to Equation 3.31.
3.7.4 Statistics
Mean values and standard deviations of the reconstructed parameters OEF, ν,
R2, χnb and S0 in grey and white matter were calculated for every subject.
Intersubject means were used to determine significant differences (p < 0.05)
between the ANN and QN reconstruction using a two-sample Student’s t-test.
Bland-Altman plots were used to visually assess correlation and agreement
of the two methods.
3.7.5 Simulation
A simulation was used in order to assess the accuracy and precision of the
ANN. Magnetic susceptibility and magnitude decay in 100 grey and white
matter voxels each were simulated exactly as during training with Y = 60 %,
ν = 4 %, R2 = 12 Hz and χnb = −40 ppb representing grey matter and Y =
60 %, ν = 2 %, R2 = 17 Hz and χnb = −50 ppb representing white matter.
Additional 100 voxels were simulated with the grey matter parameters except
that Y = 80 % representing a generic lesion. Only for simulation purposes,
two additional networks were trained in the same fashion as the first, yet, with
uniform instead of Gaussian parameter distributions constrained by (1 < Y <
98)%, (0.1 < ν < 10)%, (1 < R2 < 30)Hz and (−100 < χnb < 100)ppb.
One of the additional networks was trained on 107 parameter sets randomly
chosen from each distribution. For the other one, each parameter range was
divided into 60 equidistant steps and all possible combinations
(
1.296 · 107)
were utilised for training. The parameters were reconstructed with all three
ANNs and the QN approach and the relative deviation from the ground truth
was compared.
3.8 tissue oxygenation in high-grade gliomas
The brain tissue oxygenation parameters OEF, CBF and CMRO2 were quantified
from the GRE data of the eight patients diagnosed with high-grade glioma and
the results were compared between glioblastomas and astrocytomas. For this
purpose, machine learning was incorporated into the QSM+qBOLD approach
presented in Section 3.6 in order to make the reconstruction more robust
still. The approach described in the following is a preliminary version of the
technique proposed by Cho et al. [2019] and has been published as Hubertus
et al. [2019a].
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3.8.1 QSM+qBOLD Analysis
The GRE data was analysed with the QSM+qBOLD approach as described in Sub-
section 3.6.2 with ν being initialised according to Equation 3.2 and 3.5 respec-
tively. An additional clustering step was introduced where voxels with similar
magnitude decay were grouped together first using the X-means algorithm
[Pelleg and Moore, 2000] to determine the number of clusters. The actual
clustering was then carried out with the K-means algorithm. The Bayesian
information criterion was used as discriminator in both cases. Only one value
for Y, ν and R2 was fitted per group in order to increase the SNR with the
starting value being the average of the original starting values within the
group. The results of this initial groupwise fit were then used as starting
values for the final voxelwise fit. This voxelwise fit was stopped when the
relative change of the objective function reached 1 % or after a maximum of
30 iterations. In order to circumvent the determination of the weighting factor
in Equation 3.33, χnb was updated directly from Equation 3.34 and the other
parameters from Equation 3.37 in each iteration. CBF was estimated accord-
ing to Subsection 3.3.1 and 3.3.2 and OEF and CMRO2 were calculated using
Equation 3.31 and 3.32 respectively.
3.8.2 Statistics
ROIs were drawn around the brain tumours by a neuroradiologist with 7 years
of experience. These ROIs were mirrored at the central axis of the brain to also
obtain contralateral ROIs. Mean values and standard deviations of the recon-
structed oxygenation parameters OEF, CBF and CMRO2 were calculated in both
ROIs for glioblastoma and astrocytoma patients separately. Intersubject means
were used to determine significant differences (p < 0.05) between the tumour
and contralateral side using a two-sample Student’s t-test. In addition, ROIs
were drawn outlining small parts of the contrast-enhancing tumour (CET),
oedema (OED), normal appearing grey matter (nGM) and normal appearing
white matter (nWM). OEF versus CBF was plotted within these tissue ROIs in
order to illustrate possible trends and clusters.

4
R E S U LT S
This chapter lists and depicts the results of this thesis starting with the general
QSM pipeline implemented for this work. Afterwards the results of the three
main parts of this thesis are shown: The comparison of the GESSE and GRE
sequence for QSM+qBOLD analysis, the application of an artificial neural net-
work for QSM+qBOLD analysis of GRE data and finally the mapping of tissue
oxygenation in high-grade glioma patients. The three parts have been pub-
lished as Hubertus et al. [2019b], Hubertus et al. [2019c] and Hubertus et al.
[2019a] respectively and the corresponding descriptions and illustrations are
adapted from named publications.
4.1 qsm pipeline
Figure 4.1 illustrates one slice of the magnitude and phase images at three
different echo times as manually reconstructed from the raw GRE data of
one representative healthy volunteer. These images serve as input for the
QSM pipeline. The results from each step of the pipeline for a single slice
in a representative healthy volunteer are depicted in Figure 4.2. Only little
phase wrapping is visible in the anterior left part of the brain, which is fully
Figure 4.1: Representative slice of the GRE magnitude (top) and phase (bottom) im-
ages at three subsequent echo times from a representative healthy volun-
teer.
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removed by the spatial unwrapping. Both the RDF and χ maps reveal grey-
white matter contrast. The RDF map shows the non-local characteristics of the
dipole, which are removed in the χ map by the field to source inversion.
Figure 4.2: In vivo results of the QSM pipeline applied to the GRE data of a repre-
sentative healthy volunteer. Depicted are the estimated frequency offset
per echo ∆ϕ before and after spatial unwrapping as well as the relative
difference field RDF = ∆ϕloc/(ω0∆TE) in ppm and the magnetic suscepti-
bility χ referenced to CSF in ppb. The RDF and χ outside the brain mask
are manually set to black.
4.2 comparison of gesse and gre for qsm+qbold analysis
Figure 4.3 depicts the L-curve for one representative subject both for the GESSE
and GRE sequence. The optimal weighting factor according to L-curve theory
was either 1 or 10 for all subjects.
Figure 4.3: Choosing the weighting factor: L-curve analysis comparing QSM against
qBOLD term for one representative subject for GESSE (left) and GRE (right).
w = 1 (marked in red) was chosen as optimal weighting according to
L-curve theory in both cases.
The ratio of the relative condition numbers rCNGESSE/rCNGRE is illustrated
in Figure 4.4. It is smaller than 1 for all tested OEF and ν with a mean of 0.69.
The smallest ratio is reached for low OEF and high ν values.
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Figure 4.4: Ratio of the relative condition number rCN of the qBOLD function FqBOLD
from GESSE and GRE for a range of oxygen extraction fraction (OEF) and
deoxygenated blood volume ν. The other parameters were set to R2 =
11.5 Hz, χnb = χba + 100 ppb, S0 = 1000 a.u. and TE was adopted from
the clinical sequence respectively.
A representative slice of the relative deviation of the reconstructed parame-
ters OEF, deoxygenated blood volume ν and transverse relaxation rate R2 from
the GESSE and GRE single- and multi-compartment simulation is shown in Fig-
ure 4.5. For the single-compartment simulation, the OEF and ν from GESSE
Figure 4.5: Relative deviation from ground truth (x− xtrue)/xtrue · 100 % of recon-
structed oxygen extraction fraction (OEF), deoxygenated blood volume ν
and transverse relaxation rate R2. Representative slice from GESSE and
GRE for the single-compartment (left) and multi-compartment simulation
(right). The GESSE reconstruction has been initialised with the single mean
value of ground truth ν (first column) and the actual ground truth ν dis-
tribution (second column).
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reveal less variation within one tissue type but stronger contrast between
grey and white matter compared to GRE. When initialising the GESSE recon-
struction with the ground truth ν distribution, the grey-white matter contrast
is reduced. R2 reconstructed from GESSE is more accurate in grey and white
matter and shows no contrast in both cases. For the multi-compartment simu-
lation, all three parameters from GESSE have again lower variation within one
tissue type. OEF is slightly overestimated in grey and white matter for GRE
and strongly underestimated in white matter for GESSE. Initialising the GESSE
reconstruction with the ground truth ν distribution in this case increases the
discrepancy between grey and white matter for ν.
Table 4.1: Mean relative squared error MRSE = ((x− xtrue)/xtrue)2 of the recon-
structed oxygen extraction fraction (OEF), deoxygenated blood volume ν,
transverse relaxation rate R2, non-blood magnetic susceptibility χnb and
magnitude S0 across the whole simulated grey matter (GM) and white mat-
ter (WM) for GESSE and GRE. The GESSE reconstruction has been initialised
with the single mean value of ground truth ν (first column) and the actual
ground truth ν distribution (second column). Upper half shows results for
single-, lower half for multi-compartment simulation. The R2 component
of brain tissue was used as ground truth in the multi-compartment case.
MRSE in %
GM WM
GESSE GRE GESSE GRE
single
OEF 3 6 30 5 3 15
ν 4 9 32 10 2 8
R2 0.04 0.04 7 0.05 0.04 0.8
χnb 0.8 0.2 6 0.1 0.1 0.6
S0 0.00 0.00 0.03 0.00 0.00 0.01
multi
OEF 2 7 12 82 84 16
ν 6 82 57 8 10 6
R2 0.08 0.1 7 19 19 5
χnb 1 3 8 3 3 0.5
S0 0.00 0.00 0.03 0.01 0.01 0.03
Table 4.1 summarises the accuracy (MRSE) of all parameters reconstructed
from GESSE and GRE across grey and white matter in the full brain for the
single- and multi-compartment simulation. The accuracy of the GESSE parame-
ters is generally higher than of the GRE parameters in the single-compartment
case except for ν in white matter (10 % versus 8 %). Initialisation of the GESSE
reconstruction with the ground truth ν distribution leads to a decreased ac-
curacy of OEF and ν in grey matter but an increased accuracy in white matter
compared to the single value initialisation. In the multi-compartment case, the
GESSE accuracy of OEF (2 % versus 12 %), ν (6 % versus 57 %) and R2 (0.08 %
versus 7 %) in grey matter is higher than for GRE when the former is initial-
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ised with single value ν. The opposite holds for white matter OEF (82 % versus
16 %), ν (8 % versus 6 %) and R2 (19 % versus 5 %). Initialisation of the GESSE
reconstruction with the ν distribution does not improve accuracy of OEF, ν
and R2 in white matter and lowers it in grey matter.
Figure 4.6: Similar representative slice of the reconstructed parameter maps from
GESSE (left) and GRE (right) for subject 2: oxygen extraction fraction (OEF),
deoxygenated blood volume ν, transverse relaxation rate R2 and non-
blood magnetic susceptibility χnb.
Figure 4.7: T1-weighted image, map of the magnetic susceptibility χ, cerebral blood
flow (CBF) and cerebral metabolic rate of oxygen (CMRO2) registered to the
GESSE (left) and GRE data (right). Depicted is the same slice as in Figure 4.6.
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Figure 4.6 illustrates a similar representative slice from GESSE and GRE of
the reconstructed parameters OEF, ν, R2 and χnb. Figure 4.7 shows the same
two slices depicting the morphological reference T1-weighted image, input
parameter maps of χ and CBF as well as the resulting CMRO2 map.
Figure 4.8: Histograms showing the parameter distribution across grey and white
matter for both GESSE (orange) and GRE (blue) of subject 6. Shown are
the oxygen extraction fraction (OEF), deoxygenated blood volume ν, trans-
verse relaxation rate R2, non-blood susceptibility χnb, signal magnitude
at the spin echo and t = 0 respectively S0 and cerebral metabolic rate of
oxygen (CMRO2).
Histograms of the reconstructed GESSE and GRE parameters across GM+WM
of subject 6 are depicted in Figure 4.8. Mean and standard deviation in this
case are OEF = 35.0± 15.4 %, ν = 2.8± 0.5 % (median ± interquartile range),
R2 = 13.8± 2.5 Hz, χnb = −43± 27 ppb, S0 = 639± 199 a.u. and CMRO2 =
66± 73µmol/100 g/min for GESSE and OEF = 44.9± 5.0 %, ν = 3.2± 2.4 %
(median ± interquartile range), R2 = 14.1 ± 6.2 Hz, χnb = −42 ± 36 ppb,
S0 = 1006± 216 a.u. and CMRO2 = 89± 82µmol/100 g/min for GRE. The OEF
distribution is broader for GESSE than for GRE with the opposite being true for
ν and R2. χnb, S0 and CMRO2 have similar distributions for GESSE and GRE. ν
from GRE reveals a cutoff at roughly 1.2 %.
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Table A.1 and A.2 in the Appendix A summarise the mean values and
standard deviations of OEF, CMRO2, CBF, ν, R2 and χnb for all seven subjects
from GESSE and GRE respectively.
Table 4.2 highlights the intersubject variability by listing the mean and
standard deviation of the individual means for the same six parameters from
GESSE and GRE together with the p-value for the comparison of both se-
quences. Averaged over grey and white matter, there are significant differ-
ences (p < 0.05) between GESSE and GRE for the OEF (32.4± 1.6 versus 43.0±
5.4 %), CMRO2 (60± 15 versus 87± 13µmol/100 g/min) and ν (2.9± 0.1 versus
3.5± 0.4 %). Looking at grey and white matter separately, there are also sig-
nificant differences between GESSE and GRE for the OEF, R2 and CMRO2 both
in grey and white matter and for ν only in grey matter.
Table 4.2: Intersubject variability given by the mean± standard deviation of the indi-
vidual means for the oxygen extraction fraction (OEF), cerebral metabolic
rate of oxygen (CMRO2), cerebral blood flow (CBF), deoxygenated blood
volume ν, transverse relaxation rate R2 and non-blood magnetic suscep-
tibility χnb for GESSE and GRE. Means were calculated within combined
grey and white matter (GM+WM) as well as in grey matter (GM) and white
matter (WM) separately. p-values from Student’s t-test are stated to determ-
ine significant differences (p < 0.05) between the values from GESSE and
GRE.
GM+WM GM WM GM+WM GM WM
OEF in % CMRO2 in µmol/100g/min
GESSE 32.4± 1.6 35.0± 0.9 30.3± 2.1 60± 15 91± 24 36± 9
GRE 43.0± 5.4 43.8± 5.2 42.2± 5.6 87± 13 118± 21 56± 6
p < 0.001 < 0.001 < 0.001 < 0.01 < 0.05 < 0.001
CBF in ml/100g/min ν in %
GESSE 23.8± 5.8 34.0± 9.0 15.7± 3.8 2.9± 0.1 3.0± 0.1 2.8± 0.1
GRE 27.3± 5.6 36.8± 8.5 17.7± 3.7 3.5± 0.4 4.3± 0.6 2.8± 0.3
p 0.27 0.56 0.34 < 0.01 < 0.001 0.81
R2 in Hz χnb in ppb
GESSE 14.2± 0.5 13.4± 0.5 14.8± 0.6 −43± 5 −36± 5 −49± 7
GRE 14.4± 0.7 12.0± 0.8 16.9± 0.7 −43± 8 −40± 8 −46± 9
p 0.53 < 0.01 < 0.001 0.87 0.28 0.43
Figure 4.9 depicts a boxplot of the subject means of OEF, CMRO2, ν, R2 and
χnb from GESSE and GRE across grey and white matter, and grey matter and
white matter separately. Significant contrast (p < 0.05) between grey and
white matter is present for all five parameters from GESSE but only for CMRO2,
ν and R2 from GRE.
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Figure 4.9: Boxplot illustrat-
ing intersubject variability for
the oxygen extraction frac-
tion (OEF), cerebral metabolic
rate of oxygen (CMRO2), de-
oxygenated blood volume ν,
transverse relaxation rate R2
and non-blood magnetic sus-
ceptibility χnb for GESSE and
GRE across combined grey and
white matter (GM+WM) and
grey matter (GM) and white
matter (WM) separately. De-
picted are median (red), first
and third quartile (blue) and
whiskers at 1.5 times the
interquartile distance (black).
Significant differences (p <
0.05) both between GM and
WM within the same acquisi-
tion and between GESSE and
GRE within the same tissue are
marked with an asterisk.
The GESSE and GRE signal decay from a representative voxel in grey and
white matter, together with the corresponding fit and residuals are illustrated
in Figure 4.10. The residuals of the grey matter voxel seem randomly distrib-
uted. The white matter residuals show a peak at the spin echo for GESSE and
a linear drop during the first four echoes for the GRE. Figure 4.11 shows a
representative inferior slice of OEF and ν reconstructed from GESSE together
with the corresponding magnitude image at the last echo and the magnetic
susceptibility. Artefacts of increased OEF and ν are visible in the centre and
left anterior part of the brain, which roughly coincide with the caudate nuc-
leus, putamen, and globus pallidus outlined in blue and signal dropout in
the magnitude image outlined in green.
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Figure 4.10: Comparison of two representative voxels in grey and white matter in-
cluding signal decay, fit and residuals for GESSE (orange, left) and GRE
(blue, right) signal in vivo.
Figure 4.11: Representative inferior slice of the oxygen extraction fraction (OEF) and
deoxygenated blood volume ν reconstructed from GESSE with the corres-
ponding magnitude image at the last echo SGESSE and magnetic suscep-
tibility χ. The green ROI was drawn around the area of signal dropout
in the magnitude image and the blue ROI outlines the caudate nucleus,
putamen and globus pallidus on the magnetic susceptibility image. Arte-
facts of increased OEF and ν are visible in both areas.
72 results
4.3 artificial neural networks for qsm+qbold analysis
The training of the ANN stopped after 100 iterations taking 62 minutes with
the chosen hardware. The reconstruction time for a full in vivo data set with
the ANN is approximately one second compared to approximately one hour
with the QN approach even excluding the calculation of the L-curve.
Figure 4.12: Normalised histograms of training parameters (top) and training per-
formance of the network (bottom). The training distributions of the ve-
nous oxygen saturation Y, deoxygenated blood volume ν, transverse re-
laxation rate R2, non-blood magnetic susceptibility χnb and magnitude
after excitation S0 comprise both grey and white matter. The maximum
Y is cut off at the assumed arterial oxygen saturation Ya = 98 %. The per-
formance of the network is measured by the mean squared error (MSE)
and starts stagnating after approximately 10 iterations both for the train-
ing (left) and testing set (right).
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Figure 4.12 depicts the distributions of the parameters Y, R2, ν, χnb and
S0 that were used for training the ANN as normalised histograms and the
evolution of the ANN performance during training.
The accuracy of the parameter reconstruction in the simulation for the three
ANNs and the QN approach is displayed in Figure 4.13. Averaged over all sim-
ulated voxels, the ANN trained on normally distributed parameters is more
accurate than the ones trained on uniformly distributed parameters and has
lower variation than the QN approach. The uniformly trained ANNs specifi-
cally overestimate ν in simulated WM.
Figure 4.13: Mean and standard deviation of the relative accuracy (xrec − xtrue)/xtrue
for the reconstructed venous oxygen saturation Y, deoxygenated blood
volume ν, transverse relaxation rate R2 and non-blood magnetic sus-
ceptibility χnb. The performance of the ANN with the Gaussian (blue),
uniform (orange) and combinatorial (yellow) training parameter distri-
bution as well as of the QN approach (purple) is displayed within all
simulated voxels (total) and within grey matter (GM), white matter (WM)
and the lesion separately.
Figure 4.14 shows a representative axial, coronal and sagittal slice of the
reconstructed OEF from the ANN and QN approach from one subject. The cor-
responding T1-weighted image is given as morphological reference. Stronger
contrast between grey and white matter is visible in the ANN reconstruction.
74 results
Figure 4.14: Representative axial, coronal and sagittal slice of the oxygen extraction
fraction OEF = 1 − Y/Ya reconstructed with the artificial neural net-
work (ANN) and quasi-Newton (QN) approach. The corresponding T1-
weighted morphological reference image is given on the right.
The same axial slice of the remaining parameters ν, R2, χnb and S0 for the
ANN and QN reconstruction as well as the corresponding νstart and χ map
from QSM are illustrated in Figure 4.15. The parameter maps from the ANN
generally appear noisier than the ones from the QN approach.
Figure 4.16 shows the distribution of all reconstructed parameters across
the full brain of the same subject as normalised histograms. Mean values ±
standard deviations in grey matter are OEF = 44.1± 9.9 %, ν = 3.3± 1.9 %,
R2 = 13.4± 3.5 Hz, χnb = −17± 38 ppb, S0 = 1234± 286 a.u. for the ANN and
OEF = 36.5± 7.5 %, ν = 5.2± 2.1 %, R2 = 12.2± 5.1 Hz, χnb = −34± 33 ppb,
S0 = 1209 ± 286 a.u. for the QN approach. The values in white matter are
OEF = 46.8± 9.1 %, ν = 2.4± 1.4 %, R2 = 16.6± 2.4 Hz, χnb = −34± 28 ppb,
S0 = 1136 ± 236 a.u. for the ANN and OEF = 33.7 ± 6.2 %, ν = 3.4 ± 1.6 %,
R2 = 16.6 ± 3.1 Hz, χnb = −42 ± 28 ppb, S0 = 1117 ± 240 a.u. for the QN
approach.
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Figure 4.15: Representative axial slice of the deoxygenated blood volume ν, trans-
verse relaxation rate R2, non-blood magnetic susceptibility χnb and mag-
nitude after excitation S0 reconstructed using the artificial neural net-
work (ANN) and quasi-Newton (QN) method. The corresponding slice of
νstart used for initialisation and the magnetic susceptibility χ from QSM
used for the final QN fit are pictured on the right. The axial slice is the
same as in Figure 4.14.
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Figure 4.16: Normalised histograms across grey and white matter of the oxygen ex-
traction fraction OEF = 1− Y/Ya, deoxygenated blood volume ν, trans-
verse relaxation rate R2, non-blood magnetic susceptibility χnb and mag-
nitude after excitation S0 reconstructed from a representative subject
(Figure 4.14 and 4.15) using the artificial neural network (orange) and
quasi-Newton (blue) approach.
Boxplots of the mean reconstructed parameter values for each subject are
depicted in Figure 4.17. Mean ± standard deviation of the individual subject
means in grey and white matter from the ANN and QN reconstruction together
with the corresponding p-values are listed in Table 4.3. Significant differences
(p < 0.05) between ANN and QN were detected for OEF in white matter, for R2
in grey matter, for ν both in grey and white matter and for χnb in grey matter.
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Figure 4.17: Boxplot illustrat-
ing intersubject variability
within grey (left) and white
matter (right) for the oxy-
gen extraction fraction
OEF = 1 − Y/Ya, deoxy-
genated blood volume ν,
transverse relaxation rate R2,
non-blood magnetic suscep-
tibility χnb and magnitude
after excitation S0 recon-
structed using the artificial
neural network (ANN) and
quasi-Newton (QN) method.
Depicted are median (red),
first and third quartile (blue)
and whiskers at 1.5 times
the interquartile distance
(black). Significant differences
(p < 0.05) between the ANN
and QN approach are marked
with an asterisk.
Bland-Altman plots comparing the ANN and QN approach for all recon-
structed parameters in grey and white matter from all subjects are illustrated
in Figure 4.18. A negative linear trend and distinct grey and white matter
cluster are visible for OEF, ν and R2. The mean difference is compatible with
0 within± 1.96 · standard deviations for all parameters except S0.
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Figure 4.18: Bland-Altman plots comparing artificial neural network (ANN) and
quasi-Newton (QN) approach for the oxygen extraction fraction OEF =
1− Y/Ya, deoxygenated blood volume ν, transverse relaxation rate R2,
non-blood magnetic susceptibility χnb and magnitude after excitation S0
within grey (blue) and white matter (orange) in all seven subjects. Plot-
ted are difference = xANN − xQN over average = (xANN + xQN)/2 as
well as the mean (solid black line) and mean± 1.96 · standard deviation
(dashed black lines).
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Table 4.3: Intersubject variability given by the mean± standard deviation of the indi-
vidual means for the oxygen extraction fraction OEF = 1− Y/Ya , deoxy-
genated blood volume ν, transverse relaxation rate R2, initial magnitude
S0 and non-blood magnetic susceptibility χnb reconstructed with the ANN
and QN approach. Means were calculated within grey matter (GM) and
white matter (WM) separately. p-values from Student’s t-test are stated to
determine significant differences (p < 0.05) between the values from ANN
and QN.
GM WM GM WM GM WM
OEF in % ν in % R2 in Hz
ANN 43.5± 0.8 47.5± 1.1 3.4± 0.1 2.5± 0.2 13.5± 0.3 17.1± 0.4
QN 43.8± 5.2 42.2± 5.6 4.3± 0.6 2.8± 0.3 12.0± 0.8 16.9± 0.7
p 0.87 < 0.05 < 0.001 0.48 < 0.01 < 0.05
S0 in a.u. χnb in ppb
ANN 1062± 218 1006± 207 −25± 5 −38± 5
QN 1045± 217 985± 206 −40± 8 −46± 9
p 0.88 0.85 < 0.01 0.05
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4.4 tissue oxygenation in high-grade gliomas
Figure 4.19: Representative slice of the oxygen extraction fraction (OEF), cerebral
blood flow (CBF) and cerebral metabolic rate of oxygen (CMRO2) for one
glioblastoma (left) and astrocytoma patient (right) together with the cor-
responding T1-weighted image with gadolinium (Gd) contrast agent. The
tumour ROI and its contralateral side are outlined in blue and green re-
spectively.
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Figure 4.20: Maps of the deoxygenated blood volume ν, transverse relaxation rate
R2 and non-blood magnetic susceptibility χnb in the same representa-
tive slice of the glioblastoma (left) and astrocytoma patient (right) from
Figure 4.19. The T1-weighted image with gadolinium (Gd) contrast agent
and the tumour (blue) and contralateral ROI (green) are also depicted.
A representative slice of the reconstructed OEF, CBF and CMRO2 for one
glioblastoma and astrocytoma patient is shown in Figure 4.19. In addition, it
depicts the corresponding T1-weighted image with gadolinium (Gd) contrast
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agent with the tumour outlined in blue as well as the mirrored ROI on the
contralateral side outlined in green. The OEF maps in both patients reveal a
uniform distribution in the healthy appearing tissue with values between 20 %
and 40 %. In contrast, the OEF inside the tumour and also in the surrounding
oedema is lower with values around 10 %. The CBF is visibly increased in
the periphery of the glioblastoma; no contrast is obvious in the astrocytoma.
CMRO2 does also not reveal an obvious contrast neither in the glioblastoma
nor in the astrocytoma.
Figure 4.21: Normalised histograms of the oxygen extraction fraction (OEF), cerebral
blood flow (CBF) and cerebral metabolic rate of oxygen (CMRO2) within
the tumour (blue) and contralateral ROI (orange) of the glioblastoma (left)
and astrocytoma patient (right) as depicted in Figure 4.19.
Figure 4.20 illustrates the deoxygenated blood volume ν, transverse relaxa-
tion rate R2 and non-blood magnetic susceptibility χnb for the same represen-
tative slice of the glioblastoma and astrocytoma patient as in Figure 4.19. Con-
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Figure 4.22: Normalised histograms of the deoxygenated blood volume ν, transverse
relaxation rate R2 and non-blood magnetic susceptibility χnb within the
tumour (blue) and contralateral ROI (orange) of the glioblastoma (left)
and astrocytoma patient (right) as depicted in Figure 4.20.
trast between the tumour including the surrounding oedema and the healthy
appearing tissue is visible for ν and R2.
The distributions of OEF, CBF and CMRO2 within the tumour and contralat-
eral ROI of the glioblastoma and astrocytoma are shown in Figure 4.21. Sim-
ilarly, Figure 4.22 depicts the distributions of ν, R2 and χnb. Distinct contrast
between the two regions is visible for the OEF, ν and R2 in both tumour types
and for the CBF but only in the glioblastoma. Two separate peaks are present
in the distribution of the OEF within both tissue ROIs for the glioblastoma but
merely within the tumour for the astrocytoma. The distribution of ν consists
of only a few almost discrete values in both tissue ROIs and for both glioblas-
toma and astrocytoma.
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Figure 4.23: Plot of the oxygen extraction fraction (OEF) versus cerebral blood flow
(CBF) for ROIs inside the contrast-enhancing tumour (CET), oedema (OED),
normal appearing grey matter (nGM) and normal appearing white matter
(nWM) for the same representative glioblastoma (left) and astrocytoma
patient (right) as in Figure 4.19. The corresponding T1-weighted image
plus gadolinium contrast agent is depicted at the top with the ROIs for
CET (blue), OED (orange), nGM (yellow) and nWM (purple) outlined.
Figure 4.23 plots the OEF versus CBF within a ROI in the contrast-enhancing
tumour (CET), oedema (OED), normal appearing grey matter (nGM) and nor-
mal appearing white matter (nWM) again for the representative glioblastoma
and astrocytoma patient. Distinct clustering of the tissue types is visible with
low OEF and CBF values especially in the oedema. Yet, two groups of OEF val-
ues are also detectable in the CET, nGM and nWM of the glioblastoma and the
nGM of the astrocytoma.
The intersubject variation of the OEF, CBF and CMRO2 within the tumour
and contralateral ROI of all six glioblastoma and both astrocytoma patients is
depicted in the boxplot in Figure 4.24. Mean and standard deviation of the
individual means inside the tumour are OEF = 17.2± 6.1 %, CBF = 108.1±
83.3 ml/100 g/min, CMRO2 = 146± 123µmol/100 g/min for the glioblastoma
and OEF = 12.5± 0.5 %, CBF = 9.2± 3.9 ml/100 g/min, CMRO2 = 9± 4µmol/
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Figure 4.24: Boxplot illustrating intersubject variability for all six glioblastoma (left)
and two astrocytoma patients (right) with regard to the oxygen extrac-
tion fraction (OEF), cerebral blood flow (CBF) and cerebral metabolic rate
of oxygen (CMRO2) inside the tumour and its contralateral ROI. Depic-
ted are median (red), first and third quartile (blue) and whiskers at 1.5
times the interquartile distance (black). Significant differences (p < 0.05)
between the tumour and its contralateral ROI are marked with an aster-
isk.
100 g/min for the astrocytoma. Inside the contralateral ROI it is OEF = 24.8±
4.5 %, CBF = 29.1 ± 21.0 ml/100 g/min, CMRO2 = 51 ± 36µmol/100 g/min
for the glioblastoma and OEF = 24.5± 2.3 %, CBF = 6.9± 3.6 ml/ 100 g/min,
CMRO2 = 13± 8µmol/100 g/min for the astrocytoma. The OEF is significantly
(p < 0.05) lower in the tumour compared to the contralateral side for both
tumour types. The CBF on the other hand is significantly (p < 0.05) higher
inside the tumour but only in the glioblastoma. The CMRO2 does not show a
significant difference.

5
D I S C U S S I O N
This chapter discusses the findings of the three main parts of this thesis: The
comparison of the GESSE and GRE sequence for QSM+qBOLD analysis, the ap-
plication of an artificial neural network for QSM+qBOLD analysis of GRE data
and finally the mapping of tissue oxygenation in high-grade glioma patients.
The first and second part have been published as Hubertus et al. [2019b] and
Hubertus et al. [2019c] respectively and the corresponding descriptions are
replicated from named publications. The third part has been published as
Hubertus et al. [2019a].
5.1 comparison of gesse and gre for qsm+qbold analysis
In this part, a GESSE sequence for OEF reconstruction from combined QSM and
qBOLD was implemented and compared to the approach of Cho et al. [2018],
which relies on GRE data, using simulations and seven healthy volunteers.
The GRE data was still utilised for QSM in this initial comparison as the GESSE
sequence employed here does not yet allow sampling of the FID prior to the
refocusing pulse.
The relative condition number of FqBOLD with the chosen sequence timings
was generally lower for GESSE than GRE for a wide range of OEF and ν. This
indicates that the extensive sampling of the short- and long-term regime pos-
sible with GESSE allows for a more robust separation of these two parameters
in theory.
Moreover, this fact is underlined by the higher accuracy of the reconstructed
parameters for GESSE in the single-compartment brain simulation except for
white matter ν. However, the relative residuals of OEF and ν from GESSE
showed an obvious grey-white matter contrast in the single-compartment
simulation, which is due to the different initialisation. The GRE reconstruc-
tion is initialised with the correct ν contrast and uses this to fit for the initial
R2. The GESSE fit on the other hand assumes a single value for ν and seems
not to reach the optimal solution for the stopping criteria chosen here. Em-
ploying the GRE initialisation also for the GESSE reconstruction removes this
grey-white matter bias and even further increases the parameter accuracy.
The multi-compartment simulation on the other hand paints a different pic-
ture and yields higher accuracy of the GESSE parameters only in grey matter.
Although the echo times of GESSE mainly sample the relaxation of the tis-
sue compartment in white matter, the prolonged sampling duration seems to
make it more susceptible to the compartmentalisation than the GRE. This leads
to an overestimation of R2 in white matter entailing a strong underestimation
of OEF. Yet, one has to keep in mind that the simulated white matter here
represents a simplification as it does not include the orientation-dependent
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effects of the myelin sheaths [Bouvier et al., 2103] and, thus, the results have
to be treated with caution. Surprisingly, the initialisation of the GESSE recon-
struction with the ground truth ν distribution does not improve the accuracy
of OEF and ν but rather lowers it both in grey and white matter by promoting
even stronger grey-white matter contrast in ν. The relative residuals of the
GRE simulation show less contrast between grey and white matter especially
for the OEF; however, the OEF seems slightly overestimated in grey and white
matter as well as ν in grey matter.
The in vivo brain parameter maps and histograms also illustrate a distinct
difference between GESSE and GRE. Whereas the OEF has a broad distribution
with strong grey and white matter contrast for the former, it has a narrower
distribution with little contrast for the latter. Moreover, the mean OEF over
grey and white matter is lower for GESSE, being reduced by 4.2 % from its
starting value, compared to GRE where it is increased by 15.5 % from its ini-
tialisation. The latter is in accordance with the multi-compartment simulation
results. ν reveals the opposite behaviour having a narrower distribution for
GESSE compared to GRE with GRE showing a stronger grey and white mat-
ter contrast. The median value from GESSE deviates by 0.2 % from the mean
starting value; yet, the median value and even the distribution of ν remains
the same as the initial guess for GRE making it strongly dependent on this
first estimate. This feature is most prominent in the histogram of ν, which
seems to be cut off at roughly 1.2 %. Quantification of blood flow in white
matter from ASL is challenging due to poor SNR resulting in very low esti-
mations that yield an initial guess of approximately 1.2 % for ν according to
Equation 3.2. Hence, there might well be biases in the initial guess for ν, also
due to the empirical nature of Equation 3.2, that will propagate into the final
parameter maps. Using the single value initialisation and prior low resolu-
tion fit as implemented for GESSE, might therefore be advantageous. Similar
to ν, R2 displays a broader distribution with more noticeable grey and white
matter contrast for GRE. This actually contradicts the findings of the multi-
compartment simulation that predicted stronger contrast for GESSE. Yet, again
the simplified representation of white matter used for simulation here might
cause this inconsistency.
The intersubject mean of OEF across grey and white matter from GESSE in
vivo is significantly lower than from GRE, mirroring the trend seen in the
multi-compartment simulation. Moreover, it has lower intersubject variabil-
ity. However, both values are still within the physiological range of 30− 45 %
reported in literature [Bolar et al., 2011; He and Yablonskiy, 2007; Leenders
et al., 1990; Carpenter et al., 1991; Yamauchi et al., 1999; Diringer et al., 2000;
An and Lin, 2000; Bulte et al., 2012; Gauthier and Hoge, 2012; Wise et al.,
2013; Ito et al., 2004] with the former being at the lower and the latter at
the upper end. One possible explanation could be a general overestimation
of the OEF by the GRE sequence as seen in the multi-compartment simula-
tion. On the other hand, neglecting diffusion has shown to lead to an un-
derestimation of OEF when applying the qBOLD model to a GESSE sequence
[Dickson et al., 2010]. Accordingly, CMRO2 from GESSE is significantly lower
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than from GRE for grey and white matter and white matter alone. In contrast
to the OEF, however, the mean values are below the physiological range of
120− 180µmol/100 g/min found in literature [Bolar et al., 2011; Cho et al.,
2018; Leenders et al., 1990; Bulte et al., 2012; Gauthier and Hoge, 2012; Wise
et al., 2013; Ito et al., 2004; Zhang et al., 2015, 2017]. This seems mainly owing
to a general underestimation of the perfusion from ASL especially in grey mat-
ter. Possible reasons could be imperfect labelling [Alsop et al., 2015], varying
arrival times of the inflowing blood [Bokkers et al., 2012] and partial volume
effects due to low resolution in the ASL sequence. Yet, this issue could be over-
come by employing alternative ASL techniques in future studies [Wells et al.,
2010; von Samson-Himmelstjerna et al., 2016; Dai et al., 2013], which would
also highly benefit the initial guess for ν. Moreover, the intersubject mean of
ν is significantly lower for GESSE than for GRE. Since this only holds for grey
matter and combined grey and white matter however, this could be due to
the lower resolution of the GESSE acquisition. Still, it is also in accordance
with the multi-compartment simulation that indicated an overestimation of
ν in grey matter for GRE. Nonetheless, the value within combined grey and
white matter from both sequences is in good agreement with the literature
values from the studies of An and Lin [2002a,b] and Bulte et al. [2007] vary-
ing between 2.46 and 3.77 %. Although the mean R2 in combined grey and
white matter demonstrated no significant difference between GESSE and GRE,
the value in grey matter alone was significantly higher for GESSE, whereas
the value in white matter was significantly lower. This reduced intersubject
R2 contrast for GESSE found in vivo agrees with the visual impression gained
from the representative subject mentioned above.
Generally, the GESSE and GRE reconstructions seem to distribute the inher-
ent grey and white matter contrast differently to the underlying parameters
in vivo. The intersubject means within grey matter and white matter from
GESSE were significantly different for OEF, ν, R2, χnb and CMRO2, whereas
significant contrast was restricted to ν, R2 and CMRO2 for GRE. Uniform OEF
without grey-white matter contrast, as produced by the GRE reconstruction,
is in accordance with earlier findings from PET [Gusnard and Raichle, 2001].
The main source of grey-white matter contrast in the magnetic susceptibility
is not the deoxygenated blood volume ν but the abundance of diamagnetic
myelin in white matter [Langkammer et al., 2012; Wisnieff et al., 2015]; hence,
contrast should also be present in χnb. Both GESSE and GRE reveal more nega-
tive susceptibility in white matter with the contrast being significant only for
GESSE however.
There are also general limitations to the approach of combined qBOLD and
QSM reconstruction. For example, the large susceptibilities in deep grey mat-
ter due to iron accumulation [Zheng et al., 2013] cannot be attributed entirely
to χnb both for the GESSE and GRE reconstruction. Moreover, it relies on the
proper removal of macroscopic field inhomogeneities. Using the background
field calculated during the QSM process as presented here, seems to be suf-
ficient for the GRE data; the GESSE data, however, still suffers from signal
dropout in large areas in inferior slices close to air-tissue interfaces. These
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artefacts lead to unreliable estimations, particularly of OEF and ν. Similarly,
the GESSE signal underestimation around the spin echo in white matter might
hint at a possible remaining background field. This is an inherent disadvan-
tage of the GESSE sequence. Despite the inclusion of the spin echo, the 2D
acquisition and longer echo times make it more sensitive to field inhomogen-
eities facilitating additional signal dropout. The GRE sequence on the other
hand allows for shorter echo times and higher resolution in 3D, making it
more robust towards field inhomogeneities.
It is difficult to say which sequence is better for combined QSM+qBOLD at
this point, especially due to the lack of a comparison to a gold standard
in vivo. It is therefore that the appropriate sequence should be chosen de-
pending on the application. On the one hand, the GESSE sequence has proven
to be more accurate in simulated grey matter. Despite the grey-white mat-
ter contrast of OEF in vivo, it theoretically allows for an extension to the
multi-compartment qBOLD model [He and Yablonskiy, 2007] to account for
tissue compartmentalisation due to its extensive sampling of the signal de-
cay. Moreover, it revealed lower intersubject variability of OEF. Yet, it requires
extensive shimming and background field correction and produces lower res-
olution images with longer acquisition times. On the other hand, GRE has
a more efficient sampling and acquisition, produces fewer artefacts and is
easier to implement as it is commonly available on all scanners. All this would
greatly facilitate a clinical implementation. Possible remaining biases, such as
overestimation of the OEF or inaccurate initialisation of ν, could be overcome
by additional postprocessing steps, for example by including regularisation
[Zhang et al., 2018] or a reconstruction based on artificial neural networks
[Domsch et al., 2018]. Furthermore, whether the precision of both sequences
is sufficient to determine subtle changes in oxygenation in diseases, such as
stroke and brain tumours, remains to be investigated.
5.2 artificial neural networks for qsm+qbold analysis
In this part, an ANN was successfully implemented to quantify the OEF with
QSM+qBOLD.
Training the ANN with normally, in contrast to uniformly, distributed para-
meters generates more accurate results in simulation. For Y, R2 and χnb this is
even true when the ground truth Y deviates from the mean training value. In
case of the simulated lesion, the ANN actually even introduces a smaller bias
than the QN method. Moreover, the ANN generally has a regularising effect
on the reconstructed parameters producing a lower standard deviation for
the relative reconstructed error compared to QN. This can be interpreted as
having higher precision. However, one has to keep in mind that the amount of
regularisation is determined by the chosen standard deviation of the training
parameters. For example, the ANN will lose its sensitivity to subtle changes
of a parameter if the parameter distribution for training is too narrow. The
training parameters used here were chosen to have an appropriate tradeoff
between sensitivity and increased robustness of the reconstruction.
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Moreover, choosing two distinct training parameter distributions for grey
and white matter in contrast to an equal consideration of both tissue types,
allows the ANN to more easily disentangle the contributions of the parameters
of the qBOLD model. Accurate separation of the parameters, especially of OEF
and ν, is a general problem of qBOLD [Hubertus et al., 2019b] and is also
prominent for the ANN used by Domsch et al. [2018].
In vivo, the representative slice of the OEF reconstructed with the ANN
reveals stronger contrast between grey and white matter, which contradicts
earlier findings of uniform OEF in the resting brain using PET [Gusnard and
Raichle, 2001]. Moreover, the mean OEF value from ANN is higher than from
QN. The R2 map from the ANN seems to have a similar, albeit less strong,
grey-white matter contrast compared to the QN reconstruction whereas the ν
maps are distinctively different. No obvious differences in contrast are visible
in the representative slice of χnb and S0 between the ANN and QN reconstruc-
tion. In general however, the maps from the ANN seem noisier, which is most
probably due to the voxelwise reconstruction compared to the full brain min-
imisation used in the QN approach.
The differences present in the OEF distribution of the representative subject
are also reflected in the intersubject mean in white matter, which is signif-
icantly higher for the ANN than for the QN reconstruction. The mean OEF
in grey and white matter in both cases is at the higher end of the range of
30 % to 45 % found in literature [Bolar et al., 2011; He and Yablonskiy, 2007;
Leenders et al., 1990; An and Lin, 2003; Bulte et al., 2012; Gauthier and Hoge,
2012]. However, the ANN produces a lower intersubject variability compared
to least-squares approaches [Christen et al., 2012; Cho et al., 2018; He and
Yablonskiy, 2007; Leenders et al., 1990; An and Lin, 2003; Zhang et al., 2018].
Taking into account the negative linear trend displayed in the Bland-Altman
plot and the mean difference that is compatible with 0, the ANN implemented
here seems to have a regularising effect also on the intersubject mean OEF. A
similar trend is present in the Bland-Altman plot for R2 and ν. Two distinct
clusters for grey and white matter are visible in all three plots indicating con-
trast between the two tissue types. The ANN method reconstructs generally
higher mean χnb and S0 values; yet, only the former shows a significant differ-
ence for the intersubject mean within grey matter, probably due to the large
intersubject variation of the latter.
In order to determine how the ANN compares to QN approaches in dealing
with possible biases and artefacts in the underlying χ maps and GRE mag-
nitude images in vivo, a full sensitivity analysis is required. In addition, the
training parameters of the ANN presented here mainly represent healthy tis-
sue. Further studies, for instance examining a cohort of stroke patients where
the OEF can be assumed to deviate from 40 % in large brain areas, are neces-
sary to decide whether the chosen training parameters are also appropriate
for these cases.
One general disadvantage of neural networks for curve-fitting is the lower
flexibility of the approach. If the SNR of the data significantly changes due to
alterations of acquisition parameters for example, the network will have to
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be retrained in order to correctly account for the noise. Nonetheless, several
networks could be trained with varying SNR so that networks for a wide range
of possible noise levels are available. This makes the ANN approach even more
efficient than the least-squares QN fitting as the weighting factor actually also
needs to be adapted if the SNR changes. Similarly, if the number or spacing of
the acquired echoes is modified, the ANN also has to be retrained. However,
minimum spacing and maximum number of echoes profits both QSM and
qBOLD analysis so that alterations of these two parameters are seldom needed
after they have been optimised.
One major benefit of the ANN compared to the QN method is that it removes
the necessity of an additional ASL acquisition for initialisation of ν. The QN
reconstruction strongly depends on this first estimate as the final ν does not
deviate much from the starting value maps. Thus, any bias in νstart due to
improper labelling, partial volume effects or a different relation between CBF
and ν [Ciris et al., 2014] for instance, would directly propagate into the final
ν and all other parameter maps. This is most prominent in the lower cutoff of
the ν distribution for the representative subject. The measured CBF values in
many white matter voxels are close to 0 due to the actually low white matter
perfusion combined with the low SNR of the pCASL sequence. According to
the empirical relationship in Equation 3.2 [Leenders et al., 1990], this results
in νstart ≈ 1.2 % for all these voxels introducing a bias that remains in the
final ν maps. The ANN on the other hand does not require initialisation and
still generates contrast between grey and white matter and a rather Gaus-
sian distribution for ν. Another advantage of the ANN method is its speed.
The reconstruction time of approximately one second would allow for an on-
line reconstruction; thus, favouring a possible implementation in the clinical
routine.
Which method is more accurate in vivo can only be determined by a com-
parison to a ground truth, possibly from 15O-PET, in the end. Nonetheless,
the ANN approach presented here is a faster and, with regard to initialisation,
more robust alternative for OEF mapping from QSM+qBOLD than the tradi-
tional QN approach. Whether this increased speed and robustness comes at
the cost of lower sensitivity to subtle OEF changes in diseases, such as stroke
and brain tumours, still remains to be investigated in future clinical studies.
5.3 tissue oxygenation in high-grade gliomas
In this part, machine learning-based clustering was successfully incorporated
into the least-squares fitting procedure for QSM+qBOLD and applied to six
glioblastoma and two astrocytoma patients.
The clustering as an intermediate processing step allowed for the recon-
struction of a uniform OEF in the healthy appearing tissue with values between
20 % and 40 % as predicted for the healthy, resting brain by PET [Gusnard and
Raichle, 2001]. On the other hand, the tumour and the surrounding area of ap-
parent oedema also revealed rather uniform OEF, however, with lower values
between 10 % and 25 %. Similarly, contrast between the tumour plus surround-
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ing apparent oedema and the healthy appearing tissue is visible for ν and R2
especially for the astrocytoma. ν is higher and R2 is lower inside the tumour
plus surrounding apparent oedema compared to the healthy appearing tissue.
The increased water content in the oedema would lead to a decrease in R2;
yet, there is no physiological explanation for the homogeneously increased ν.
This is most likely caused by a combination of the clustering and the fact that
it is difficult to properly disentangle the microscopic and mesoscopic effects
in the qBOLD model when the signal is slowly decaying, i. e. when R2 is low.
Generally, the higher the water content inside the tissue, the less accurate the
qBOLD model becomes.
Remnants of the intermediate clustering are also visible in the histograms
of the OEF and ν. The OEF reveals two separate distributions both within
the tumour ROI and the contralateral side. Even more prominently, ν shows
rather discrete values in both cases. This is in accordance with earlier findings
[Hubertus et al., 2019b,c] that the final ν maps from QSM+qBOLD do not de-
viate much from their starting values. Hence, the introduction of clustering
into the QSM+qBOLD reconstruction seems to increase the robustness of the
method; yet, it might also introduce biases especially for ν. It is therefore that
a comparison to a ground truth, for example from 15O-PET is crucial in order
to determine whether the contrast seen in the tumour is actually owing to
physiology and not to a failure of the model for instance.
Distinct groups for the separate tissue ROIs can be detected in the OEF
versus CBF plot. The plot indicates a negative correlation among contrast-
enhancing tumour, normal appearing grey matter and normal appearing
white matter, especially for the glioblastoma, which is in accordance with
the study by Preibisch et al. [2017] that used a multi-parametric qBOLD ap-
proach [Christen et al., 2011]. In contrast to Preibisch et al. [2017] however,
the method implemented here is able to reconstruct the actual OEF in % rather
than a ‘relative’ OEF. Moreover, some voxels in the contrast-enhancing tumour
and especially oedema revealed both low OEF and CBF, which might allow for
a possible distinction between still viable and non-viable tissue.
The intersubject comparison of the oxygenation parameters found a sig-
nificantly reduced OEF inside the tumour compared to the contralateral ROI
both for the glioblastoma and astrocytoma. This is in accordance with the
study of Stadlbauer et al. [2017] that also used a multi-parametric qBOLD
approach. However, the technique presented here, enables the reconstruc-
tion of a more uniform OEF in the healthy appearing tissue as predicted
by physiology [Gusnard and Raichle, 2001]. In addition, a significantly in-
creased CBF inside the tumour was found but only for the glioblastoma. This
also agrees with physiology as glioblastomas are known to promote extensive
angiogenesis and are considered to be among the most vascularised solid tu-
mour types [Hardee and Zagzag, 2012; Wen and Kesari, 2008]. The product of
OEF and CBF, the CMRO2 revealed no significant contrast. This contradicts the
findings from Stadlbauer et al. [2017] who measured a significantly increased
CMRO2 inside the tumour for high-grade glioma. One possible explanation
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could be the much smaller patient cohort (8 versus 62) employed in the study
presented here.
Using machine learning in cooperation with QSM+qBOLD to map the tissue
oxygenation in high-grade glioma as implemented here is a promising ap-
proach. It not only reproduces the findings of earlier multi-parametric qBOLD
studies [Preibisch et al., 2017; Stadlbauer et al., 2017] but also enables the
reconstruction of an absolute OEF that is uniform and in a physiologically
meaningful range in healthy appearing tissue. Moreover, as the underlying
GRE sequence is a highly efficient standard MRI sequence, the approach might
facilitate a wider clinical implementation. This is critical since further clinical
studies with larger patient cohorts of varying tumour grades and especially
a comparison to a ground truth from 15O-PET for instance is mandatory to
establish the approach presented here as valuable addition to the diagnosis,
treatment planning and response assessment of glioma patients.
6
C O N C L U S I O N A N D O U T L O O K
The objective of this thesis was to include QSM into an optimised MRI-based
reconstruction of the brain tissue oxygenation and to evaluate its application
especially to patients suffering from high-grade glioma.
In the first part of this work, a comparison between the GESSE and GRE se-
quence for quantification of the OEF with a QSM+qBOLD analysis was carried
out. GESSE outperformed GRE at accurate parameter estimation in grey matter
simulations. Yet, it produced unphysiological grey-white matter contrast in
the OEF in vivo. GRE revealed slight biases in the reconstructed parameters in
simulation; however, it provided uniform OEF maps in vivo with higher spa-
tial and temporal resolution. Hence, which sequence is better for QSM+qBOLD
reconstruction, should be decided based on the desired application. Nonethe-
less, the GRE sequence is favourable with regard to a clinical implementation.
As a standard MRI sequence it is readily available on every scanner and fur-
thermore allows for higher resolution images in a shorter scan time. Utmost
effort should be put into removing background inhomogeneities when using
GESSE and obtaining accurate parameter initialisation maps when using GRE.
The second part focused on implementing an artificial neural network to
map the OEF from a QSM+qBOLD approach. Compared to the least-squares fit-
ting using quasi-Newton optimisation from the first part, the ANN was much
faster, did not require parameter initialisation from additional acquisitions
and generated OEF maps with lower intersubject variability. Hence, the in-
clusion of machine learning is a further promising step towards a clinical
implementation of QSM+qBOLD.
Lastly, machine learning-based clustering was incorporated into the least-
squares fitting QSM+qBOLD approach in order to further increase its robust-
ness. This technique was then applied to six glioblastoma and two astrocy-
toma patients. A significantly reduced OEF was found in the tumours com-
pared to the contralateral side for both tumour types as well as a significantly
increased CBF, however only for the glioblastoma. The CMRO2 revealed no
significant differences. The QSM+qBOLD method proposed here was able to
reproduce some findings of previous multi-parametric qBOLD studies; yet, in
addition, it generated uniform OEF maps in the healthy appearing tissue with
physiologically sound values.
Exploiting the full information, i. e. the phase and magnitude, of a GESSE or
GRE sequence for reconstruction of the OEF inside the brain with a QSM+qBOLD
approach is remarkably promising. The incorporation of machine learning
techniques further increases the robustness and speed of the highly sensi-
tive qBOLD reconstruction, which could particularly facilitate a clinical imple-
mentation. Nevertheless, additional studies with a larger cohort of glioma
patients are necessary to determine the optimal tradeoff between robustness
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and sensitivity to subtle changes of the underlying oxygenation parameters
for the QSM+qBOLD approaches presented here. Similarly, a comparison to a
gold standard, for example 15O-PET is vital to determine the accuracy and
sensitivity of the method. After such a validation, the technique could be in-
cluded into radio- and chemotherapy treatment planning and also utilised
for assessment of treatment response. Moreover, the general method might
also be applicable to any pathology affecting the brain metabolism including
stroke or addiction for instance.
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a.2 tables
The following two tables summarise the mean values and standard deviations
of OEF, CMRO2, CBF, ν, R2 and χnb for all seven subjects reconstructed from
the GESSE and GRE sequence respectively as mentioned in Section 4.2.
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